Followers | 395 |
Posts | 17,865 |
Boards Moderated | 1 |
Alias Born | 06/07/2018 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MJNA Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022
Press Release | 02/15/2022
SAN DIEGO, CA, Feb. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® achieved its largest revenue month in the company’s history in its Japan and South Africa divisions in January 2022.
According to Business Insider Africa, Africa’s cannabis industry is projected to grow beyond a $7 billion valuation by 2023. Reach and Markets highlights that the Asia-Pacific market is also expected to grow exponentially with a CAGR of 28.6% from 2020 to 2027.
“Being able to achieve four best revenue months in a row in the Japan market has been both a great way to end 2021 and an inspiring way to start 2022,” said Medical Marijuana, Inc. CEO Blake Schroeder. “Now that we’ve reached this milestone in South Africa as well, we anticipate that both regions will be major market areas for us this year and beyond.”
To learn more about Kannaway®, please visit the Company online at https://www.kannaway.com/.
About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.
CONTACT:
Public Relations Contact:
Kathryn Brown
Account Director
CMW Media
P. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com
$FMNJ Franklin Mining signs Agreement for Lithium Development
Press Release | 02/15/2022
Carson City, NV, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Franklin Mining CEO William Petty (OTC Pink: FMNJ) has returned from South America, where he was negotiating projects for the company based in Argentina and Bolivia. Most promising among the many proposed agreements is a Joint Venture signed with SOCRAM Energia S.A. to develop a lithium mine in Northern Argentina.
The mine would be developed in a region known as the Lithium Triangle, which contains more than 75% of the world’s known supply of lithium. Franklin Mining would develop one mine in three stages; stage one would undertake 1,458 hectares, stage two would process 2,366 hectares, and the final stage would extract 1,409 hectares of lithium.
“Now that preliminary studies have been completed, Franklin Mining will re-register the company in Argentina, set up an office in accordance with local laws, and begin to conduct our due diligence,” confided CEO William Petty. “This area is extremely well-known for lithium production and as of right now, the results are proving to be strong and favorable.”
Franklin Mining plans to corroborate the preliminary studies prior to breaking ground on the new lithium project. First, the lithium will be extracted as raw material in order to be sold to potential end buyers. Once possible, however, Mr. Petty has plans to negotiate within a free-trade zone in order to establish a plant to process the lithium in order to sell directly to battery manufacturers.
In accordance with the Amazon for Life project, as well as other local humanitarian efforts, the company plans to improve the quality of life for people living close to the lithium mine. By utilizing eco-friendly extraction techniques, as well as conscious consumption of local land and water sources, Franklin Mining is confident in their ability to sustain the ecosystem surrounding the mine.
Safe Harbor Act: This release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.
For additional information, visit our website at www.FranklinMining.com, email: FranklinMining.CEO@gmail.com or follow us on Twitter @FMNJ1864.
$FMNJ Franklin Mining signs Agreement for Lithium Development
Press Release | 02/15/2022
Carson City, NV, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Franklin Mining CEO William Petty (OTC Pink: FMNJ) has returned from South America, where he was negotiating projects for the company based in Argentina and Bolivia. Most promising among the many proposed agreements is a Joint Venture signed with SOCRAM Energia S.A. to develop a lithium mine in Northern Argentina.
The mine would be developed in a region known as the Lithium Triangle, which contains more than 75% of the world’s known supply of lithium. Franklin Mining would develop one mine in three stages; stage one would undertake 1,458 hectares, stage two would process 2,366 hectares, and the final stage would extract 1,409 hectares of lithium.
“Now that preliminary studies have been completed, Franklin Mining will re-register the company in Argentina, set up an office in accordance with local laws, and begin to conduct our due diligence,” confided CEO William Petty. “This area is extremely well-known for lithium production and as of right now, the results are proving to be strong and favorable.”
Franklin Mining plans to corroborate the preliminary studies prior to breaking ground on the new lithium project. First, the lithium will be extracted as raw material in order to be sold to potential end buyers. Once possible, however, Mr. Petty has plans to negotiate within a free-trade zone in order to establish a plant to process the lithium in order to sell directly to battery manufacturers.
In accordance with the Amazon for Life project, as well as other local humanitarian efforts, the company plans to improve the quality of life for people living close to the lithium mine. By utilizing eco-friendly extraction techniques, as well as conscious consumption of local land and water sources, Franklin Mining is confident in their ability to sustain the ecosystem surrounding the mine.
Safe Harbor Act: This release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.
For additional information, visit our website at www.FranklinMining.com, email: FranklinMining.CEO@gmail.com or follow us on Twitter @FMNJ1864.
$SPZI Spooz, Inc. (SPZI) Announces its Unique and Diverse Plan to Generate Revenue from Global Forest Acquisitions
Press Release | 02/15/2022
Clearwater, FL., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Spooz, Inc. (OTC: SPZI) (“SPZI” or the “Company”), an innovative hedging and trading company focused on developing technologies to enhance the acquisition of significant commodity assets, entities that produce commodities, and vertical service providers that support producers, announces its unique and diverse plan to generate revenue. The Company’ plans to generate revenue from its global forest acquisitions utilizing its three divisions; Spooz Technologies LLC, Spooz Asset Management LLC, and Spooz Forestry Services LLC.
Spooz Technology LLC.
The Company’s proprietary speculative trading.
Hedging and speculative trading for the Spooz Commodity Assets Pool, LLC. (the “Pool”).
Spooz Asset Management LLC (“SAM”)
As a registered Commodity Pool Operator with the National Futures Association and the Pool’s manager, SAM will be participating in the Carbon Sequestration industry which is classified as “green” energy and will enable the Company to produce and sell carbon offset credits. Revenues from these sales will be derived from three primary sources; Pool, large individual forest owners and cooperatives that Spooz will organize and manage.
Producing and selling carbon offset credits entitles the producer to a tax credit that is freely transferable, the tax credit can be larger than the revenue generated from the sale of carbon credits rendering those revenues tax free
Spooz Forestry Management, LLC
A forestry asset holder division selling carbon offset credits utilizing carbon income contracts shared with forest owners.
Contracts to perform forestry management services include:
Maintain or increase extent of forest ecosystem.
Sustain fundamental ecological functions
Reduce competition for moisture, nutrients, and light.
Enhance forest recovery following disturbance.
Prioritize management of locations that provide high value across the landscape.
Maintain or enhance existing carbon stocks while retaining forest character.
Enhance or maintain sequestration capacity through significant forest alterations.
Paul Strickland, the Spooz CEO stated, “as the Company continues to progress by achieving its first quarter goals it is negotiating the acquisition of certain forest assets and will continue to seek and evaluate certain target properties that satisfy the financial criteria established in favor of carbon sequestration and corporate profitability.”
About Spooz, Inc. (SPZI)
Spooz, Inc. (the “Company”) is an innovative hedging and trading company focused on developing technologies to facilitate the acquisition and value maximization from significant commodity assets, including entities that produce commodities, and vertical service providers that support producers. The Company’s technologies manage access to electronically, exchange traded assets that can be combined with the cash commodity business to algorithmically streamline and hedge diverse sources of revenue.
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange — including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions — are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company’s control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any manner whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.
Company Contact:
Paul D. Strickland, Jr., CEO
pstrickland@spooz.com
312.402.7737 Office
Website: http://www.Spooz.com (under development)
Twitter: http://www.Twitter.com/SpoozInc
Facebook: http://www.Facebook.com/SpoozInc (new)
Email: PStrickland@Spooz.com
$SPZI Spooz, Inc. (SPZI) Announces its Unique and Diverse Plan to Generate Revenue from Global Forest Acquisitions
Press Release | 02/15/2022
Clearwater, FL., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Spooz, Inc. (OTC: SPZI) (“SPZI” or the “Company”), an innovative hedging and trading company focused on developing technologies to enhance the acquisition of significant commodity assets, entities that produce commodities, and vertical service providers that support producers, announces its unique and diverse plan to generate revenue. The Company’ plans to generate revenue from its global forest acquisitions utilizing its three divisions; Spooz Technologies LLC, Spooz Asset Management LLC, and Spooz Forestry Services LLC.
Spooz Technology LLC.
The Company’s proprietary speculative trading.
Hedging and speculative trading for the Spooz Commodity Assets Pool, LLC. (the “Pool”).
Spooz Asset Management LLC (“SAM”)
As a registered Commodity Pool Operator with the National Futures Association and the Pool’s manager, SAM will be participating in the Carbon Sequestration industry which is classified as “green” energy and will enable the Company to produce and sell carbon offset credits. Revenues from these sales will be derived from three primary sources; Pool, large individual forest owners and cooperatives that Spooz will organize and manage.
Producing and selling carbon offset credits entitles the producer to a tax credit that is freely transferable, the tax credit can be larger than the revenue generated from the sale of carbon credits rendering those revenues tax free
Spooz Forestry Management, LLC
A forestry asset holder division selling carbon offset credits utilizing carbon income contracts shared with forest owners.
Contracts to perform forestry management services include:
Maintain or increase extent of forest ecosystem.
Sustain fundamental ecological functions
Reduce competition for moisture, nutrients, and light.
Enhance forest recovery following disturbance.
Prioritize management of locations that provide high value across the landscape.
Maintain or enhance existing carbon stocks while retaining forest character.
Enhance or maintain sequestration capacity through significant forest alterations.
Paul Strickland, the Spooz CEO stated, “as the Company continues to progress by achieving its first quarter goals it is negotiating the acquisition of certain forest assets and will continue to seek and evaluate certain target properties that satisfy the financial criteria established in favor of carbon sequestration and corporate profitability.”
About Spooz, Inc. (SPZI)
Spooz, Inc. (the “Company”) is an innovative hedging and trading company focused on developing technologies to facilitate the acquisition and value maximization from significant commodity assets, including entities that produce commodities, and vertical service providers that support producers. The Company’s technologies manage access to electronically, exchange traded assets that can be combined with the cash commodity business to algorithmically streamline and hedge diverse sources of revenue.
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange — including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions — are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company’s control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any manner whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.
Company Contact:
Paul D. Strickland, Jr., CEO
pstrickland@spooz.com
312.402.7737 Office
Website: http://www.Spooz.com (under development)
Twitter: http://www.Twitter.com/SpoozInc
Facebook: http://www.Facebook.com/SpoozInc (new)
Email: PStrickland@Spooz.com
$CRDV Community Redevelopment Announces Launch of New Division - Mosaic Homes
Press Release | 02/15/2022
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Community Redevelopment (OTC: CRDV) ("the Company"), a developer of community oriented real estate in urban and suburban markets with a focus on all aspects of the real estate development cycle, announced today that it has launched its new division, Mosaic Homes and signed a LOI for a residential redevelopment joint venture in Biscayne Park, FL. A LOI for a second project is currently under negotiation, and Community Redevelopment is in talks for a LOI on a third project.
The launch of Mosaic Homes by Community Redevelopment is another step toward the Company’s mission. Mosaic Homes will build or rehabilitate for-sale single family, townhomes, and condominium residential properties with an eye toward inspired sustainability. The Company will be working toward acquiring infill lots to build or to renovate properties with a focus on sustainable improvements.
For the Company’s first project, in conjunction with its joint venture partner, it will acquire the property in Biscayne Park and undertake development and construction work as is necessary to sell the upgraded single-family property upon the end of the investment period. Mosaic Homes will be responsible for all development activities.
Biscayne Park has a median property value of $457,300 in 2019, which is 1.9 times larger than the national average of $240,500. Between 2018 and 2019, the median property value increased from $405,700 to $457,300, a 12.7% increase. Biscayne Park is a triangular-shaped residential neighborhood just north of Miami Shores. Founded in the 1920’s by Arthur Griffing, who was the landscape architect for the famous Carl Fisher, this area has been one of Miami’s best kept secrets. As a result of its close proximity to Miami, this community with beautiful tree lined streets is seeing a revitalization as potential residents see the beauty in the traditional modern Miami homes of Biscayne Park.
Community Redevelopment offers investors an opportunity to participate in the growth and upside of trends in the real estate market by being a shareholder. As an owner of shares of common stock, investors experience significantly increased liquidity as compared to owning real estate.
Myron Jones, Head of Development for Community Redevelopment, said, "This residential redevelopment joint venture is the first of what could be many for Mosaic Homes. For our Company, we acquire equity in the project and each project chosen will have very strong upside potential as well as will improve the sustainability and help enhance the neighborhoods where we are investing. We chose Biscayne Park for our first project under Mosaic Homes, as a result of its green history, close proximity to Miami, and the rapid growth in its real estate market. This residential redevelopment project is basically a template for future projects wherever we see opportunity to make an impact."
About Community Redevelopment
Community Redevelopment affords potential investors a significant opportunity to participate in the process of identifying and redeveloping entire communities and regional areas, via a publicly traded company. Community Redevelopment Inc. is a full-service real estate company with a management team that has extensive experience in acquiring, developing, constructing, and managing high-quality multifamily, and retail properties in attractive markets throughout the Mid-Atlantic and Southeastern United States, as well as capital markets. The Company is focused on all aspects of the real estate development cycle including land development, design build, property operations, and site redevelopment. In addition to the ownership of our operating property portfolio, Community Redevelopment plans to develop and build desirable properties for its own account and through joint ventures with affiliated and unaffiliated partners.
Community Redevelopment, Inc. is focused on community development in urban and suburban markets and our mission is to integrate our proprietary business model by providing sustainable, long-term value to investors as we strive to provide opportunities to improve neighborhoods with residential, commercial, and industrial development projects while designing architecturally pleasing, clean, energy efficient communities and commercial structures. For more information on Community Redevelopment Inc., please contact us at (954) 233-1481, or (800) 210-9438 for those outside of the calling area. You may also visit our website at www.comredev.com.
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest 10-Q Report filed on November 16, 2021. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time. Finally, the investing public is reminded that the only announcements or information about Community Redevelopment Inc. which are condoned by the Company must emanate from the Company itself and bear our name as its Source.
For Investor Relations, please contact:
David Kugelman
(800) 210-9438 extension 5
(404) 281-8556 Mobile and WhatsApp
Skype: kugsusa
ir@comredev.com
$CRDV Community Redevelopment Announces Launch of New Division - Mosaic Homes
Press Release | 02/15/2022
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Community Redevelopment (OTC: CRDV) ("the Company"), a developer of community oriented real estate in urban and suburban markets with a focus on all aspects of the real estate development cycle, announced today that it has launched its new division, Mosaic Homes and signed a LOI for a residential redevelopment joint venture in Biscayne Park, FL. A LOI for a second project is currently under negotiation, and Community Redevelopment is in talks for a LOI on a third project.
The launch of Mosaic Homes by Community Redevelopment is another step toward the Company’s mission. Mosaic Homes will build or rehabilitate for-sale single family, townhomes, and condominium residential properties with an eye toward inspired sustainability. The Company will be working toward acquiring infill lots to build or to renovate properties with a focus on sustainable improvements.
For the Company’s first project, in conjunction with its joint venture partner, it will acquire the property in Biscayne Park and undertake development and construction work as is necessary to sell the upgraded single-family property upon the end of the investment period. Mosaic Homes will be responsible for all development activities.
Biscayne Park has a median property value of $457,300 in 2019, which is 1.9 times larger than the national average of $240,500. Between 2018 and 2019, the median property value increased from $405,700 to $457,300, a 12.7% increase. Biscayne Park is a triangular-shaped residential neighborhood just north of Miami Shores. Founded in the 1920’s by Arthur Griffing, who was the landscape architect for the famous Carl Fisher, this area has been one of Miami’s best kept secrets. As a result of its close proximity to Miami, this community with beautiful tree lined streets is seeing a revitalization as potential residents see the beauty in the traditional modern Miami homes of Biscayne Park.
Community Redevelopment offers investors an opportunity to participate in the growth and upside of trends in the real estate market by being a shareholder. As an owner of shares of common stock, investors experience significantly increased liquidity as compared to owning real estate.
Myron Jones, Head of Development for Community Redevelopment, said, "This residential redevelopment joint venture is the first of what could be many for Mosaic Homes. For our Company, we acquire equity in the project and each project chosen will have very strong upside potential as well as will improve the sustainability and help enhance the neighborhoods where we are investing. We chose Biscayne Park for our first project under Mosaic Homes, as a result of its green history, close proximity to Miami, and the rapid growth in its real estate market. This residential redevelopment project is basically a template for future projects wherever we see opportunity to make an impact."
About Community Redevelopment
Community Redevelopment affords potential investors a significant opportunity to participate in the process of identifying and redeveloping entire communities and regional areas, via a publicly traded company. Community Redevelopment Inc. is a full-service real estate company with a management team that has extensive experience in acquiring, developing, constructing, and managing high-quality multifamily, and retail properties in attractive markets throughout the Mid-Atlantic and Southeastern United States, as well as capital markets. The Company is focused on all aspects of the real estate development cycle including land development, design build, property operations, and site redevelopment. In addition to the ownership of our operating property portfolio, Community Redevelopment plans to develop and build desirable properties for its own account and through joint ventures with affiliated and unaffiliated partners.
Community Redevelopment, Inc. is focused on community development in urban and suburban markets and our mission is to integrate our proprietary business model by providing sustainable, long-term value to investors as we strive to provide opportunities to improve neighborhoods with residential, commercial, and industrial development projects while designing architecturally pleasing, clean, energy efficient communities and commercial structures. For more information on Community Redevelopment Inc., please contact us at (954) 233-1481, or (800) 210-9438 for those outside of the calling area. You may also visit our website at www.comredev.com.
Forward-Looking Statements
This announcement contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest 10-Q Report filed on November 16, 2021. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time. Finally, the investing public is reminded that the only announcements or information about Community Redevelopment Inc. which are condoned by the Company must emanate from the Company itself and bear our name as its Source.
For Investor Relations, please contact:
David Kugelman
(800) 210-9438 extension 5
(404) 281-8556 Mobile and WhatsApp
Skype: kugsusa
ir@comredev.com
$COWI CarbonMeta Technologies (COWI) and Salvum Partner to Deliver EarthCrete(TM) Pavers to Supernova Energy
Press Release | 02/15/2022
First project will be a commercial solar panel installation project in California
WOODINVILLE, WA and SANTA ANA, CA / ACCESSWIRE / February 15, 2022 / CarbonMeta Technologies Inc. (OTC PINK:COWI) and Salvum Corporation today announced they have signed a Memorandum of Understanding (MoU) for a joint cooperation to deliver EarthCrete™ Cementless Concrete Pavers to Supernova Energy Corporation.
The partnership's first project will include delivery of EarthCrete™ Cementless Concrete Pavers for a commercial solar panel installation project in California.
"We are excited to work with Salvum on supplying sustainable and renewable construction products to Supernova Energy, a leading provider of commercial and residential solar panel solutions," said Lloyd Spencer, president and CEO of CarbonMeta. "Through this partnership, CarbonMeta and Salvum can develop and deliver building products that mitigate climate change by capturing carbon dioxide (CO2) for renewable energy projects."
Installing EarthCrete™ Cementless Concrete Pavers offers construction contractors and their customers a lower carbon footprint alternative compared with traditional building materials.
"We are thrilled to be working with CarbonMeta and Salvum to help Supernova Energy continue delivering cutting-edge renewable energy solutions," said Christopher Bridwell, CEO of Supernova Energy. "Working together, we can deliver renewable energy solutions that also use construction products that can help mitigate climate change."
About Supernova Energy Corporation
Supernova Energy Corporation, headquartered in Huntington Beach, California, provides a multitude of commercial solar solutions specifically tailored for commercial or residential application, including stainless steel hardware used in each installation to assure long life performance. Supernova retains civil, structural and electrical engineering partners as needed for each project to guarantee your system installation is designed to the highest standards, in compliance with state and local building codes.
For more information about Supernova Energy Corporation, please visit https://SupernovaEnergy.Solar/
About Salvum Corporation
Salvum Corporation is headquartered in Santa Ana, California. Salvum's mission is to set the highest standard for safe, protective, durable, cradle-to cradle, recycled, Earth Conscious® and decarbonized building materials that uniquely address and overcome existing limitations of current materials using Salvum's proprietary technologies that decarbonize the planet, specifically addressing the embodied carbon dilemma of the built environment.
For more information about Salvum Corporation, please visit www.earthcrete.com and www.salvumcorp.com
About CarbonMeta Technologies Inc.
CarbonMeta Technologies (OTC PINK:COWI) is a resource reclamation company that will process organic wastes and generate economically sustainable hydrogen and high-value carbon products. CarbonMeta's includes plastic and construction waste upcycling to help address the world's pollution and climate crises. The company is based in Woodinville, Washington, and has several subsidiaries, each with its own focus on high-value solutions for environmental sustainability.
For more information about CarbonMeta Technologies and its subsidiaries, please visit www.CarbonMetaTech.com.
Forward-Looking Statement
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The ability of the Company to complete and file its Fiscal Year 2016 annual report on Form 10K relies on third parties to complete their activities. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include among others, the inherent uncertainties associated with smaller reporting companies, including without limitation, other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
CONTACT INFORMATION
Mark Duiker
CarbonMeta Technologies Investor Relations
(844) 698-3777, option 3
Investor@CarbonMetaTech.com
$COWI CarbonMeta Technologies (COWI) and Salvum Partner to Deliver EarthCrete(TM) Pavers to Supernova Energy
Press Release | 02/15/2022
First project will be a commercial solar panel installation project in California
WOODINVILLE, WA and SANTA ANA, CA / ACCESSWIRE / February 15, 2022 / CarbonMeta Technologies Inc. (OTC PINK:COWI) and Salvum Corporation today announced they have signed a Memorandum of Understanding (MoU) for a joint cooperation to deliver EarthCrete™ Cementless Concrete Pavers to Supernova Energy Corporation.
The partnership's first project will include delivery of EarthCrete™ Cementless Concrete Pavers for a commercial solar panel installation project in California.
"We are excited to work with Salvum on supplying sustainable and renewable construction products to Supernova Energy, a leading provider of commercial and residential solar panel solutions," said Lloyd Spencer, president and CEO of CarbonMeta. "Through this partnership, CarbonMeta and Salvum can develop and deliver building products that mitigate climate change by capturing carbon dioxide (CO2) for renewable energy projects."
Installing EarthCrete™ Cementless Concrete Pavers offers construction contractors and their customers a lower carbon footprint alternative compared with traditional building materials.
"We are thrilled to be working with CarbonMeta and Salvum to help Supernova Energy continue delivering cutting-edge renewable energy solutions," said Christopher Bridwell, CEO of Supernova Energy. "Working together, we can deliver renewable energy solutions that also use construction products that can help mitigate climate change."
About Supernova Energy Corporation
Supernova Energy Corporation, headquartered in Huntington Beach, California, provides a multitude of commercial solar solutions specifically tailored for commercial or residential application, including stainless steel hardware used in each installation to assure long life performance. Supernova retains civil, structural and electrical engineering partners as needed for each project to guarantee your system installation is designed to the highest standards, in compliance with state and local building codes.
For more information about Supernova Energy Corporation, please visit https://SupernovaEnergy.Solar/
About Salvum Corporation
Salvum Corporation is headquartered in Santa Ana, California. Salvum's mission is to set the highest standard for safe, protective, durable, cradle-to cradle, recycled, Earth Conscious® and decarbonized building materials that uniquely address and overcome existing limitations of current materials using Salvum's proprietary technologies that decarbonize the planet, specifically addressing the embodied carbon dilemma of the built environment.
For more information about Salvum Corporation, please visit www.earthcrete.com and www.salvumcorp.com
About CarbonMeta Technologies Inc.
CarbonMeta Technologies (OTC PINK:COWI) is a resource reclamation company that will process organic wastes and generate economically sustainable hydrogen and high-value carbon products. CarbonMeta's includes plastic and construction waste upcycling to help address the world's pollution and climate crises. The company is based in Woodinville, Washington, and has several subsidiaries, each with its own focus on high-value solutions for environmental sustainability.
For more information about CarbonMeta Technologies and its subsidiaries, please visit www.CarbonMetaTech.com.
Forward-Looking Statement
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The ability of the Company to complete and file its Fiscal Year 2016 annual report on Form 10K relies on third parties to complete their activities. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include among others, the inherent uncertainties associated with smaller reporting companies, including without limitation, other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
CONTACT INFORMATION
Mark Duiker
CarbonMeta Technologies Investor Relations
(844) 698-3777, option 3
Investor@CarbonMetaTech.com
$INTK Industrial Nanotech Inc Announces Expansion Into Railroad Tank Car Insulation
Press Release | 02/14/2022
Industrial Nanotech Inc Announces Expansion Into Railroad Tank Car Insulation
PR Newswire
BROOMFIELD, Colo., Feb. 14, 2022
BROOMFIELD, Colo., Feb. 14, 2022 /PRNewswire/ -- Industrial Nanotech Inc, (Pink Sheets: INTK).
Today, Industrial Nanotech announced that the Company has reached an agreement with a railroad tank car owner to provide thermal insulation for the tank cars they own and operate. They will also be the exclusive distributor to the railroad tank car industry globally. Additional details on the new partner will be disclosed in an upcoming joint press release.
The initial focus will be on 9300 cars. There are approximately 500,000 tank cars in the US. The revenue to the Company per tank car is approximately $35,000 US.
"This is a market we are uniquely qualified to benefit," states Stuart Burchill, CEO/CTO of Industrial Nanotech Inc. "Railroad tank cars are limited by the Department of Transportation with regard to weight, length, width, and height. By replacing the existing insulation with a thinner and lighter insulation, we increase the volume and weight available for product carried per tank car, with no increase in cost per mile of transport distance. For this industry, our product will pay for itself in weeks."
To handle the anticipated large inquiry of demand, Industrial Nanotech is looking to hire three additional sales representatives by the end of Q2. Interested applicants can send resumes to answers@syneffex.com.
About Industrial Nanotech, Inc.
Industrial Nanotech Inc. is a global nanoscience solutions and product development leader. See www.industrial-nanotech.com for more information.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise/update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Cision View original content:https://www.prnewswire.com/news-releases/industrial-nanotech-inc-announces-expansion-into-railroad-tank-car-insulation-301481533.html
$INTK Industrial Nanotech Inc Announces Expansion Into Railroad Tank Car Insulation
Press Release | 02/14/2022
Industrial Nanotech Inc Announces Expansion Into Railroad Tank Car Insulation
PR Newswire
BROOMFIELD, Colo., Feb. 14, 2022
BROOMFIELD, Colo., Feb. 14, 2022 /PRNewswire/ -- Industrial Nanotech Inc, (Pink Sheets: INTK).
Today, Industrial Nanotech announced that the Company has reached an agreement with a railroad tank car owner to provide thermal insulation for the tank cars they own and operate. They will also be the exclusive distributor to the railroad tank car industry globally. Additional details on the new partner will be disclosed in an upcoming joint press release.
The initial focus will be on 9300 cars. There are approximately 500,000 tank cars in the US. The revenue to the Company per tank car is approximately $35,000 US.
"This is a market we are uniquely qualified to benefit," states Stuart Burchill, CEO/CTO of Industrial Nanotech Inc. "Railroad tank cars are limited by the Department of Transportation with regard to weight, length, width, and height. By replacing the existing insulation with a thinner and lighter insulation, we increase the volume and weight available for product carried per tank car, with no increase in cost per mile of transport distance. For this industry, our product will pay for itself in weeks."
To handle the anticipated large inquiry of demand, Industrial Nanotech is looking to hire three additional sales representatives by the end of Q2. Interested applicants can send resumes to answers@syneffex.com.
About Industrial Nanotech, Inc.
Industrial Nanotech Inc. is a global nanoscience solutions and product development leader. See www.industrial-nanotech.com for more information.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise/update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Cision View original content:https://www.prnewswire.com/news-releases/industrial-nanotech-inc-announces-expansion-into-railroad-tank-car-insulation-301481533.html
$IVRO IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results
Press Release | 02/14/2022
Placentia, California--(Newsfile Corp. - February 14, 2022) - InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter of 2022, ending December 31, 2021, compared to revenues and net income of $201,255 and $67,663, respectively, for its first fiscal quarter of 2021. The first fiscal quarter of 2022 earnings benefitted from its second government PPP loan forgiveness much as it did in first fiscal quarter of 2021 (see www.otcmarkets.com/stock/IVRO/financials).
IVRO Chairman and CEO, W. Richard Ulmer, commented, "Our ability to increase new customer activities and continue to execute on our strategic growth plan despite the global supply chain issues stemming from COVID-19 was possible due to a $1.3 million cash rich and debt free balance sheet. All else being equal, we have no doubt that our financial strength from being a publicly traded company will prove to be the key factor in our ability to meet our strategic goals in what can easily be defined as a highly fragmented marketplace."
IVRO President, Atul Jhalani, added: "The global shift toward non-animal testing continues to gain traction and support from the majority of the planet. This will enable us to implement our strategic plan of expanding our presence in new industries, forming new strategic partnerships, while continuing to focus on generating year-over-year organic growth."
To be added to the Company's email list please click this link or for additional information, please call our investor relations department at 818-926-5441.
About InVitro International, Inc.
InVitro International, Inc., headquartered in Placentia, California, was founded in 1985 and is a customer and technology-driven provider of non-animal testing methods. The Company's testing technologies are designed to produce data regarding corrosivity and ocular/dermal irritation, which correlate with animal and human test results. IVRO's technology is commercialized globally through test kits and partner laboratory services.
This release may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements. These risks and uncertainties include but are not limited to: acceptance of the Company's technologies by customers or regulatory agencies, changes in market conditions and other competitive factors. The forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update such statements.
Company Contact:
W. Richard Ulmer
Chief Executive Officer and Chairman
(800)246-8487
invitro@invitrointl.com
www.invitrointl.com
$IVRO IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results
Press Release | 02/14/2022
Placentia, California--(Newsfile Corp. - February 14, 2022) - InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter of 2022, ending December 31, 2021, compared to revenues and net income of $201,255 and $67,663, respectively, for its first fiscal quarter of 2021. The first fiscal quarter of 2022 earnings benefitted from its second government PPP loan forgiveness much as it did in first fiscal quarter of 2021 (see www.otcmarkets.com/stock/IVRO/financials).
IVRO Chairman and CEO, W. Richard Ulmer, commented, "Our ability to increase new customer activities and continue to execute on our strategic growth plan despite the global supply chain issues stemming from COVID-19 was possible due to a $1.3 million cash rich and debt free balance sheet. All else being equal, we have no doubt that our financial strength from being a publicly traded company will prove to be the key factor in our ability to meet our strategic goals in what can easily be defined as a highly fragmented marketplace."
IVRO President, Atul Jhalani, added: "The global shift toward non-animal testing continues to gain traction and support from the majority of the planet. This will enable us to implement our strategic plan of expanding our presence in new industries, forming new strategic partnerships, while continuing to focus on generating year-over-year organic growth."
To be added to the Company's email list please click this link or for additional information, please call our investor relations department at 818-926-5441.
About InVitro International, Inc.
InVitro International, Inc., headquartered in Placentia, California, was founded in 1985 and is a customer and technology-driven provider of non-animal testing methods. The Company's testing technologies are designed to produce data regarding corrosivity and ocular/dermal irritation, which correlate with animal and human test results. IVRO's technology is commercialized globally through test kits and partner laboratory services.
This release may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements. These risks and uncertainties include but are not limited to: acceptance of the Company's technologies by customers or regulatory agencies, changes in market conditions and other competitive factors. The forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update such statements.
Company Contact:
W. Richard Ulmer
Chief Executive Officer and Chairman
(800)246-8487
invitro@invitrointl.com
www.invitrointl.com
$SMCE Former Goldman Sachs Senior Investment Banker Joins the Board of SMC/Genesis Financial as Independent Director.
Press Release | 02/14/2022
Charleston, SC, Feb. 14, 2022 (GLOBE NEWSWIRE) -- SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE) and its majority-owned subsidiary, Genesis Financial, Inc. (“Genesis”) - an integrated financial technology company (“Fintech”) with a full suite of digital financial services solutions, is pleased to announce that on February 9th the company appointed Ms. Sachie McQueen to the Board of Directors.
Ms. McQueen is an acknowledged senior investment banker with over 10 years of global equity sales and research experience in top investment banks such as Goldman Sachs and Credit Suisse. She has been rated Top 3 in Institutional Investors Magazine survey for five consecutive years from 2004-2009. In 2010, Ms. McQueen started working at Amazon.com INC headquarters in Seattle serving as a senior financial analyst providing financial analysis and oversight for Amazon's financial operations.
Quoting Ms. McQueen “I am extremely excited to join the SMC/Genesis Financial as an Independent Director. Knowing that the Company has such high growth potentials, unique opportunities and strong pipelines in the $3.9 billion Australian Wealth Management industry, I am looking forward to contributing my experience and expertise in the financial industry to expand the business, explore new sources and connect the two nations with my fellow Board members. I look forward to helping the company execute in the near future”
“I am honored and look forward to having Sachie join our Board. She not only brings substantial financial business experience but a meaningful understanding of international markets. This compliments the group we are assembling to provide a worldwide investment organization providing products and services to our clients and Advisors without being hampered by geographic boarders.” Stated Chuck Provini Chairman of the Board
About Genesis Financial, Inc.
Genesis, with 23 employees under its purview along with 120 financial consultants, advisors, and representatives, is a fully integrated financial technology company with a full suite of digital financial services solutions. Genesis, focusing on fintech-powered wealth management services, operated its business through two Australian regulated entities in wealth management, tax and accounting advisory services. The two operating subsidiaries are the Ballast Group and The Financial Link Group. For more information, visit www.ballast.com.au and www.tflg.com.au.
The Australian Wealth Management industry has over 25,000 financial advisors managing 2.2 million investors. The annual fees generated by the Wealth Management industry is close to $3.9 billion. According to AITE (2020) at least 10 million adults are underserved or not served at all by the Australian Financial Advisors. Genesis has firmly positioned itself to acquire and consolidate to expand in Australia's fragmented Independent Dealer Group business sector.
About SMC Entertainment, Inc.
SMC is a versatile holding company focused on acquisition and support of proven commercialized financial services and technology (fintech) companies. SMC's multi-discipline growth by acquisition approach is to enhance revenues and shareholder equity. For more information on SMC, visit www.smceinc.com.
Press Release Contact:
Erik Blum
President
SMC Entertainment, Inc.
ron.hughes.operations@gmail.com
Safe Harbor Statement
This press release contains statements, which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of the Company, members of its management, and assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
$SMCE Former Goldman Sachs Senior Investment Banker Joins the Board of SMC/Genesis Financial as Independent Director.
Press Release | 02/14/2022
Charleston, SC, Feb. 14, 2022 (GLOBE NEWSWIRE) -- SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE) and its majority-owned subsidiary, Genesis Financial, Inc. (“Genesis”) - an integrated financial technology company (“Fintech”) with a full suite of digital financial services solutions, is pleased to announce that on February 9th the company appointed Ms. Sachie McQueen to the Board of Directors.
Ms. McQueen is an acknowledged senior investment banker with over 10 years of global equity sales and research experience in top investment banks such as Goldman Sachs and Credit Suisse. She has been rated Top 3 in Institutional Investors Magazine survey for five consecutive years from 2004-2009. In 2010, Ms. McQueen started working at Amazon.com INC headquarters in Seattle serving as a senior financial analyst providing financial analysis and oversight for Amazon's financial operations.
Quoting Ms. McQueen “I am extremely excited to join the SMC/Genesis Financial as an Independent Director. Knowing that the Company has such high growth potentials, unique opportunities and strong pipelines in the $3.9 billion Australian Wealth Management industry, I am looking forward to contributing my experience and expertise in the financial industry to expand the business, explore new sources and connect the two nations with my fellow Board members. I look forward to helping the company execute in the near future”
“I am honored and look forward to having Sachie join our Board. She not only brings substantial financial business experience but a meaningful understanding of international markets. This compliments the group we are assembling to provide a worldwide investment organization providing products and services to our clients and Advisors without being hampered by geographic boarders.” Stated Chuck Provini Chairman of the Board
About Genesis Financial, Inc.
Genesis, with 23 employees under its purview along with 120 financial consultants, advisors, and representatives, is a fully integrated financial technology company with a full suite of digital financial services solutions. Genesis, focusing on fintech-powered wealth management services, operated its business through two Australian regulated entities in wealth management, tax and accounting advisory services. The two operating subsidiaries are the Ballast Group and The Financial Link Group. For more information, visit www.ballast.com.au and www.tflg.com.au.
The Australian Wealth Management industry has over 25,000 financial advisors managing 2.2 million investors. The annual fees generated by the Wealth Management industry is close to $3.9 billion. According to AITE (2020) at least 10 million adults are underserved or not served at all by the Australian Financial Advisors. Genesis has firmly positioned itself to acquire and consolidate to expand in Australia's fragmented Independent Dealer Group business sector.
About SMC Entertainment, Inc.
SMC is a versatile holding company focused on acquisition and support of proven commercialized financial services and technology (fintech) companies. SMC's multi-discipline growth by acquisition approach is to enhance revenues and shareholder equity. For more information on SMC, visit www.smceinc.com.
Press Release Contact:
Erik Blum
President
SMC Entertainment, Inc.
ron.hughes.operations@gmail.com
Safe Harbor Statement
This press release contains statements, which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of the Company, members of its management, and assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
$ATDS Data443 Wins Multi-Year Contract with Major US Energy Provider with Over 30,000 Employees
Press Release | 02/14/2022
3 Year Contract Delivers Data Governance and Entity Extraction with Machine Learning Capabilities – Reducing Risk Profile
RESEARCH TRIANGLE PARK, NC, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. ("Data443" or the "Company") (OTCPK: ATDS), a leading data security and privacy software company, today announced a new 3-year agreement with a leading US-based energy provider and its 18 subsidiaries – providing gas, wind, nuclear and other energy sources in the southeast US.
This fast-moving organization has committed to a long-term subscription license that will be paid up-front for Data443's Data Identification Manager ™, the leading data identification, classification, migration, and privacy management offering. Data443's Data Identification Manager identifies information in various repositories – including Microsoft's Sharepoint, OpenText, M-Files – and makes intelligent and programmatic decisions based on business rules and trained machine learning rules to migrate, dispose or archive data. Most importantly – it assigns risk values to information sets so the organization may react accordingly.
Leading the market in data discovery capabilities for years, with over 900 sensitive data policies in 14 languages that greatly reduce false positives and ensure organizations don't have to become taxonomy experts, Data443's data management platforms continue to garner deep trustworthiness and operational success in the field – with customers and industry analysts alike.
Jason Remillard, Data443's Founder and Chief Executive Officer, commented, "Data has become one of the most valuable assets in today’s organizations. Ensuring its security, placement, processing activities and other risk factors for the business continues to be a challenge for any organization of any size. This energy provider customer is facing additional challenges posed by recent policy changes from the White House around critical infrastructure requirements and regulations."
"Data443 excels in situations with customers facing changing requirements and rapid movements of information. Our growing customer base agrees with this assessment. We take our role in securing critical services, data, and indeed – people – very seriously and continue to make that our main mission as we progress through massive shifts in IT services, spending, and demands from clients," concluded Mr. Remillard.
Data443 offers several licensing models: individual, small business, and major enterprise bundles. Additionally, there are sell-with bundles that match valuable Data443 products that directly benefit users and enterprises.
Clients can learn more directly at: https://data443.com/data-identification-manager/
About Data443 Risk Mitigation, Inc.
Data443 Risk Mitigation, Inc. (OTCPK: ATDS) is an industry leader in All Things Data Security®, providing software and services to enable secure data across local devices, networks, cloud, and databases, at rest and in flight. With over 3,000 customers in over 100 countries, Data443 provides a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform, or format. Our industry-leading framework helps customers prioritize risk, identify security gaps, and implement overall data protection and privacy management strategies.
For more information, please visit https://www.data443.com
To learn more about Data443, please watch our video introduction on our YouTube channel:
$ATDS Data443 Wins Multi-Year Contract with Major US Energy Provider with Over 30,000 Employees
Press Release | 02/14/2022
3 Year Contract Delivers Data Governance and Entity Extraction with Machine Learning Capabilities – Reducing Risk Profile
RESEARCH TRIANGLE PARK, NC, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. ("Data443" or the "Company") (OTCPK: ATDS), a leading data security and privacy software company, today announced a new 3-year agreement with a leading US-based energy provider and its 18 subsidiaries – providing gas, wind, nuclear and other energy sources in the southeast US.
This fast-moving organization has committed to a long-term subscription license that will be paid up-front for Data443's Data Identification Manager ™, the leading data identification, classification, migration, and privacy management offering. Data443's Data Identification Manager identifies information in various repositories – including Microsoft's Sharepoint, OpenText, M-Files – and makes intelligent and programmatic decisions based on business rules and trained machine learning rules to migrate, dispose or archive data. Most importantly – it assigns risk values to information sets so the organization may react accordingly.
Leading the market in data discovery capabilities for years, with over 900 sensitive data policies in 14 languages that greatly reduce false positives and ensure organizations don't have to become taxonomy experts, Data443's data management platforms continue to garner deep trustworthiness and operational success in the field – with customers and industry analysts alike.
Jason Remillard, Data443's Founder and Chief Executive Officer, commented, "Data has become one of the most valuable assets in today’s organizations. Ensuring its security, placement, processing activities and other risk factors for the business continues to be a challenge for any organization of any size. This energy provider customer is facing additional challenges posed by recent policy changes from the White House around critical infrastructure requirements and regulations."
"Data443 excels in situations with customers facing changing requirements and rapid movements of information. Our growing customer base agrees with this assessment. We take our role in securing critical services, data, and indeed – people – very seriously and continue to make that our main mission as we progress through massive shifts in IT services, spending, and demands from clients," concluded Mr. Remillard.
Data443 offers several licensing models: individual, small business, and major enterprise bundles. Additionally, there are sell-with bundles that match valuable Data443 products that directly benefit users and enterprises.
Clients can learn more directly at: https://data443.com/data-identification-manager/
About Data443 Risk Mitigation, Inc.
Data443 Risk Mitigation, Inc. (OTCPK: ATDS) is an industry leader in All Things Data Security®, providing software and services to enable secure data across local devices, networks, cloud, and databases, at rest and in flight. With over 3,000 customers in over 100 countries, Data443 provides a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform, or format. Our industry-leading framework helps customers prioritize risk, identify security gaps, and implement overall data protection and privacy management strategies.
For more information, please visit https://www.data443.com
To learn more about Data443, please watch our video introduction on our YouTube channel:
$BONZ Marvion™? Signs Memorandum of Understanding with Euro Amazing Limited for Movie Adaptation Rights in an Aggregate Value of US$50million
Press Release | 02/14/2022
Marvion™? Signs Memorandum of Understanding with Euro Amazing Limited for Movie Adaptation Rights in an Aggregate Value of US$50million
PR Newswire
SINGAPORE, Feb. 14, 2022
SINGAPORE, Feb. 14, 2022 /PRNewswire/ -- Bonanza Goldfields Corp. (OTC:BONZ) is pleased to announce that Marvion™? has inked a Memorandum of Understanding (MOU) with Euro Amazing Limited. The agreement allows Marvion™? to acquire up to 10 licences for each of 10 types of adaptation rights with respect to a portfolio of 100 movies from Euro Amazing Limited. The value of these 10,000 licences will have an aggregated value of US$50million.
The accumulation of a large portfolio of intellectual property rights and licences in the media and entertainment industry is one of the focus of Marvion™? in 2022 as it aspires to become the largest global marketplace for Hybrid NFTs™? that are the digital ownership titles (DOTs) to media and entertainment intellectual property rights and licences.
Commenting on the partnership with Euro Amazing Limited, Julian So, Vice Chairman of Marvion™? said, "We are constantly seeking meaningful partnerships with industry heavyweights to add value to the media and entertainment scene and we are very happy that our goals are aligned with Euro Amazing Limited, which we hope will be the first of many such partnerships. We aim to disrupt the media and entertainment industry by minting movie and other media remake and other rights and licenses into hybrid-NFTs, creating a simple and convenient method for industry players to easily access and trade such licences in a central location, the Marvion MetaStudio."
About BONZ
The Bonanza Goldfields Corporation is developing business initiatives joining the latest blockchain technologies, through market merger and acquisitions to develop advanced media distribution solutions.
About Marvion™?
Marvion™? is a metaverse blockchain technology company, unlocking, enhancing and preserving the value of media and entertainment intellectual property through blockchain and related technologies to create Hybrid NFTs™?. The company's vision is to offer the ultimate artist and fan engagement, leveraging technology in both digital metaverse and physical experience realms. Marvion™? will be adopting their Hybrid NFT™? (h-NFT) format across all minted NFTs. The h-NFTs will undergo full know-your-client (KYC) and verification processes prior to Marvion™? acquiring the intellectual property. This is to ensure that only authentic and high quality NFTs are available on the platform.
More Information about Marvion™?:
Website: marvion.media
Facebook: facebook.com/marvionmetaverse
Instagram: instagram.com/marvion.media
Twitter: twitter.com/marvion_media
LinkedIn: linkedin.com/company/marvion
Telegram: t.me/marvion_media
About Hybrid NFT™ (h-NFT)
A h-NFT is an integrated, best in class, digital ownership title (DOT) that contains a smart contract that can execute transactions and also contains the specific legal terms of the intellectual property ownership, license and/or rights. Each Hybrid NFT™? (h-NFT) contains the following:
A copy of the SPA for the purchase of the master license.
Evidence or warranty of ownership of the relevant intellectual property.
Ownership of the sub-license detailing the rights of the h-NFT holder.
Image/video/music or other file depending on what the asset is.
For media queries, please contact:
Parkson Yip
Marketing and PR Team
Media@Marvion.Media
Cision View original content:https://www.prnewswire.com/news-releases/marvion-signs-memorandum-of-understanding-with-euro-amazing-limited-for-movie-adaptation-rights-in-an-aggregate-value-of-us50million-301481272.html
$DEFTF DeFi Technologies Launches Valour Polkadot and Cardano ETPs on the Frankfurt Stock Exchange
Press Release | 02/14/2022
DeFi Technologies Launches Valour Polkadot and Cardano ETPs on the Frankfurt Stock Exchange
Canada NewsWire
TORONTO, Feb. 14, 2022
Trading of two new exchange traded products (ETPs) - Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR - begins today, February 14, 2022.
The ETPs will enable retail and institutional investors to gain exposure to the DOT and ADA tokens simply and securely via their bank or broker.
TORONTO, Feb. 14, 2022 /CNW/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies'') (NEO: DEFI) (GR: RMJR) (OTC: DEFTF), a technology company bridging the gap between traditional capital markets and decentralised finance, announced today that Valour Inc. ("Valour"), its wholly owned subsidiary and a pioneer in digital asset ETPs, received approval to begin trading Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR on the Boerse Frankfurt Zertifikate AG (''Frankfurt Stock Exchange"). Trading of Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR begins today, February 14, 2022.
DeFi Technologies Logo (CNW Group/DeFi Technologies, Inc.)
The new ETPs will enable both retail and institutional investors to gain exposure to the native tokens of the Polkadot and Cardano networks as easily as buying shares from their bank or broker.
"We are expanding our product offerings in the large German market through these listings on Boerse Frankfurt. In Scandinavia, where Valour Polkadot and Cardano are already listed, we have seen a big interest in these crypto assets. We look forward to empowering more investors throughout Europe to have access to leading industry ETPs", says Tommy Fransson, CEO of Valour.
The Valour Polkadot (DOT) EUR ETP (ISIN CH1114178812) precisely tracks the price of DOT, the native token of the Polkadot protocol. The Polkadot network, after years of development, has advanced in bringing Ethereum Virtual Machine (EVM compatibility) to its parachain network by onboarding Moonbeam GLMR. Valour's Polkadot ETP makes investment in this leading decentralised platform simple, secure, and cost-effective. DOT is currently among the top fifteen cryptocurrencies in the world by market capitalization, at USD$21.65 billion as of Feb 10, 2022.
The Valour Cardano (ADA) EUR ETP (ISIN CH1114178820) tracks the performance of the native token of Cardano, the governance token of the world's largest decentralised exchange. Valour's Cardano ETP makes investment in this leading decentralised finance (DeFi) platform cost-effective, easier and more secure. DOT is currently among the top ten cryptocurrencies in the world by market capitalization, at USD$40.18 billion as of Feb 10, 2022.
Valour offers fully hedged digital asset ETPs with low to zero management fees, with product listings across four European exchanges. Valour's existing product range includes Valour Uniswap (UNI), Cardano (ADA), Polkadot (DOT) and Solana (SOL) ETPs, as well as Valour's flagship Bitcoin Zero and Valour Ethereum Zero products, the first fully hedged, passive investment product with Bitcoin (BTC) and Ethereum (ETH) as underlyings which are completely fee-free, with competitors still charging up to 2.5% in management fees.
Learn more about DeFi Technologies and Valour at defi.tech and valour.com.
About DeFi Technologies
DeFi Technologies Inc. is a technology company bridging the gap between traditional capital markets and decentralised finance. Our mission is to expand investor access to industry-leading decentralised technologies which we believe lie at the heart of the future of finance. On behalf of our shareholders and investors, we identify opportunities and areas of innovation, and build and invest in new technologies and ventures in order to provide trusted, diversified exposure across the decentralized finance ecosystem. For more information or to subscribe to receive company updates and financial information, visit https://defi.tech/.
About Valour
Valour Inc. issues exchange-listed financial products that enable retail and institutional investors to access investment in disruptive innovations, such as digital assets, in a simple and secure way. Established in 2019 and based in Zug, Switzerland, Valour is a wholly owned subsidiary of DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF). For more information on Valour, visit www.valour.com.
Cautionary note regarding forward-looking information:
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the approval of Metaverse Index ETP by SFSA; the metaverse and potential market size; the growth of AUM; expansion of DeFi Technologies and Valour into other markets and geographic areas; the growth and adoption of decentralized finance; the pursuit by DeFi Technologies and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited to acceptance of Valour ETPs, including the Metaverse Index ETP, by stock exchanges; investor demand for DeFi Technologies' and Valour's products; the growth and development of DeFi, the metaverse and cryptocurrency sector; rules and regulations with respect to DeFi and cryptocurrency; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
THE NEO STOCK EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/defi-technologies-launches-valour-polkadot-and-cardano-etps-on-the-frankfurt-stock-exchange-301481449.html
$DEFTF DeFi Technologies Launches Valour Polkadot and Cardano ETPs on the Frankfurt Stock Exchange
Press Release | 02/14/2022
DeFi Technologies Launches Valour Polkadot and Cardano ETPs on the Frankfurt Stock Exchange
Canada NewsWire
TORONTO, Feb. 14, 2022
Trading of two new exchange traded products (ETPs) - Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR - begins today, February 14, 2022.
The ETPs will enable retail and institutional investors to gain exposure to the DOT and ADA tokens simply and securely via their bank or broker.
TORONTO, Feb. 14, 2022 /CNW/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies'') (NEO: DEFI) (GR: RMJR) (OTC: DEFTF), a technology company bridging the gap between traditional capital markets and decentralised finance, announced today that Valour Inc. ("Valour"), its wholly owned subsidiary and a pioneer in digital asset ETPs, received approval to begin trading Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR on the Boerse Frankfurt Zertifikate AG (''Frankfurt Stock Exchange"). Trading of Valour Polkadot (DOT) EUR and Valour Cardano (ADA) EUR begins today, February 14, 2022.
DeFi Technologies Logo (CNW Group/DeFi Technologies, Inc.)
The new ETPs will enable both retail and institutional investors to gain exposure to the native tokens of the Polkadot and Cardano networks as easily as buying shares from their bank or broker.
"We are expanding our product offerings in the large German market through these listings on Boerse Frankfurt. In Scandinavia, where Valour Polkadot and Cardano are already listed, we have seen a big interest in these crypto assets. We look forward to empowering more investors throughout Europe to have access to leading industry ETPs", says Tommy Fransson, CEO of Valour.
The Valour Polkadot (DOT) EUR ETP (ISIN CH1114178812) precisely tracks the price of DOT, the native token of the Polkadot protocol. The Polkadot network, after years of development, has advanced in bringing Ethereum Virtual Machine (EVM compatibility) to its parachain network by onboarding Moonbeam GLMR. Valour's Polkadot ETP makes investment in this leading decentralised platform simple, secure, and cost-effective. DOT is currently among the top fifteen cryptocurrencies in the world by market capitalization, at USD$21.65 billion as of Feb 10, 2022.
The Valour Cardano (ADA) EUR ETP (ISIN CH1114178820) tracks the performance of the native token of Cardano, the governance token of the world's largest decentralised exchange. Valour's Cardano ETP makes investment in this leading decentralised finance (DeFi) platform cost-effective, easier and more secure. DOT is currently among the top ten cryptocurrencies in the world by market capitalization, at USD$40.18 billion as of Feb 10, 2022.
Valour offers fully hedged digital asset ETPs with low to zero management fees, with product listings across four European exchanges. Valour's existing product range includes Valour Uniswap (UNI), Cardano (ADA), Polkadot (DOT) and Solana (SOL) ETPs, as well as Valour's flagship Bitcoin Zero and Valour Ethereum Zero products, the first fully hedged, passive investment product with Bitcoin (BTC) and Ethereum (ETH) as underlyings which are completely fee-free, with competitors still charging up to 2.5% in management fees.
Learn more about DeFi Technologies and Valour at defi.tech and valour.com.
About DeFi Technologies
DeFi Technologies Inc. is a technology company bridging the gap between traditional capital markets and decentralised finance. Our mission is to expand investor access to industry-leading decentralised technologies which we believe lie at the heart of the future of finance. On behalf of our shareholders and investors, we identify opportunities and areas of innovation, and build and invest in new technologies and ventures in order to provide trusted, diversified exposure across the decentralized finance ecosystem. For more information or to subscribe to receive company updates and financial information, visit https://defi.tech/.
About Valour
Valour Inc. issues exchange-listed financial products that enable retail and institutional investors to access investment in disruptive innovations, such as digital assets, in a simple and secure way. Established in 2019 and based in Zug, Switzerland, Valour is a wholly owned subsidiary of DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF). For more information on Valour, visit www.valour.com.
Cautionary note regarding forward-looking information:
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the approval of Metaverse Index ETP by SFSA; the metaverse and potential market size; the growth of AUM; expansion of DeFi Technologies and Valour into other markets and geographic areas; the growth and adoption of decentralized finance; the pursuit by DeFi Technologies and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited to acceptance of Valour ETPs, including the Metaverse Index ETP, by stock exchanges; investor demand for DeFi Technologies' and Valour's products; the growth and development of DeFi, the metaverse and cryptocurrency sector; rules and regulations with respect to DeFi and cryptocurrency; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
THE NEO STOCK EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/defi-technologies-launches-valour-polkadot-and-cardano-etps-on-the-frankfurt-stock-exchange-301481449.html
$ONPH Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Press Release | 02/14/2022
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC PINK:RGBPP): announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in humans with pancreatic cancer of Regen's patented ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES ("MRNA Vaccines").
In April of 2021 ONPH was granted an exclusive right and license for the development and commercialization of the MRNA Vaccines for the treatment in humans of pancreatic cancer.
The current intent is that IND ("Investigational New Drug Application") enabling studies are to be commenced and completed with Regen providing the scientific expertise, laboratory access and modified mRNA and cellular manufacturing needed to complete the studies and ONPH providing the required financing.
This patented technology (patent issued in Aug, 2021) is a cellular vaccine that uses a modified mRNA molecule expressing peptides of Survivin which are exposed to dendritic cells. These dendritic cells are then matured and infused into the cancer patient's circulation where they are expected to hone in on the cancer and destroy it. There are currently several clinical trials ongoing around the world using Survivin as a vaccine for multiple different cancers which further supports this approach.
"I am very excited to get our newly patented modified mRNA technology advanced to the point whereby an IND can be submitted to the FDA," says David Koos, CEO and Chairman of Regen. "I expect that once our experimental protocols are set up, the path to a cleared IND from the FDA will be straightforward."
"Due to the COVID pandemic, the FDA now understands the excellent safety profile of modified mRNA technology," says the CEO of ONPH. "We believe this technology which targets Survivin and uses the patient's own immune system to kill their tumors will have the same success in treating pancreatic cancer that the CAR-T cell approach is having in liquid tumors."
The initiation and completion of the abovementioned is contingent upon several factors including, but not limited to, the execution of one or more mutually acceptable definitive agreements between the parties and securing of adequate financing. Although the parties are confident that any and all contingencies can be satisfied no assurance can be given that any such agreements shall be executed or, if executed, shall not contain terms and conditions materially different from the terms and conditions currently contemplated or that adequate financing can be secured.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the 'Company') is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
About Regen BioPharma Inc.:
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
FORWARD LOOKING STATEMENTS
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include risks related to licensing arrangements and joint ventures, including the need to negotiate the definitive agreements for the relationships; possible failure to realize anticipated benefits of business relationships, and costs of providing funding to these business relationships. Other risks and uncertainties relating to the Company include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition; the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; management of growth; and, other risks and uncertainties. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position.
CONTACTS:
For additional information, please contact the Oncology Pharma at:
One Sansome Street, Suite 3500
San Francisco, CA 94104
Phone: 415-869-1038
Fax: 415-946-8801
website: www.oncology-pharma.com
email: info@oncology-pharma.com
$ONPH Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Press Release | 02/14/2022
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC PINK:RGBPP): announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in humans with pancreatic cancer of Regen's patented ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES ("MRNA Vaccines").
In April of 2021 ONPH was granted an exclusive right and license for the development and commercialization of the MRNA Vaccines for the treatment in humans of pancreatic cancer.
The current intent is that IND ("Investigational New Drug Application") enabling studies are to be commenced and completed with Regen providing the scientific expertise, laboratory access and modified mRNA and cellular manufacturing needed to complete the studies and ONPH providing the required financing.
This patented technology (patent issued in Aug, 2021) is a cellular vaccine that uses a modified mRNA molecule expressing peptides of Survivin which are exposed to dendritic cells. These dendritic cells are then matured and infused into the cancer patient's circulation where they are expected to hone in on the cancer and destroy it. There are currently several clinical trials ongoing around the world using Survivin as a vaccine for multiple different cancers which further supports this approach.
"I am very excited to get our newly patented modified mRNA technology advanced to the point whereby an IND can be submitted to the FDA," says David Koos, CEO and Chairman of Regen. "I expect that once our experimental protocols are set up, the path to a cleared IND from the FDA will be straightforward."
"Due to the COVID pandemic, the FDA now understands the excellent safety profile of modified mRNA technology," says the CEO of ONPH. "We believe this technology which targets Survivin and uses the patient's own immune system to kill their tumors will have the same success in treating pancreatic cancer that the CAR-T cell approach is having in liquid tumors."
The initiation and completion of the abovementioned is contingent upon several factors including, but not limited to, the execution of one or more mutually acceptable definitive agreements between the parties and securing of adequate financing. Although the parties are confident that any and all contingencies can be satisfied no assurance can be given that any such agreements shall be executed or, if executed, shall not contain terms and conditions materially different from the terms and conditions currently contemplated or that adequate financing can be secured.
ABOUT ONCOLOGY PHARMA, INC.
ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the 'Company') is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
About Regen BioPharma Inc.:
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
FORWARD LOOKING STATEMENTS
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include risks related to licensing arrangements and joint ventures, including the need to negotiate the definitive agreements for the relationships; possible failure to realize anticipated benefits of business relationships, and costs of providing funding to these business relationships. Other risks and uncertainties relating to the Company include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition; the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; management of growth; and, other risks and uncertainties. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position.
CONTACTS:
For additional information, please contact the Oncology Pharma at:
One Sansome Street, Suite 3500
San Francisco, CA 94104
Phone: 415-869-1038
Fax: 415-946-8801
website: www.oncology-pharma.com
email: info@oncology-pharma.com
$UATG UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected
Press Release | 02/14/2022
Tampa, FL, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today that it has begun fulfilling purchase orders and contracts for orthopedic distributors and clients nationwide.
Ossifix engineers and manufactures 100% allograft bone implants for small bone, extremities, and sports medicine markets that also has applications in the craniofacial, spine and oral surgery procedures. Resorbable implant technology is readily accepted and used in today’s market, both domestically and globally. No regulatory approval is required for implantable fixation engineered from allograft bone. As a result, barriers to entry into the market for Ossifix Technologies implants are minimal.
Ossifix Orthopedics™ products are manufactured from select, high-density, allograft cortical bone. Ossifixs’ unique manufacturing process and patent pending designs yield an engineered cortical bone implant that provides secure fixation and virtually eliminates any allergic or autoimmune reactions associated with metal or plastic/polymer implants. All Ossifix Orthopedics™ Pin, Screw and Plate Systems are single-use surgical kits with all necessary instruments for implantation and are based on decades of clinical experience and use in the operating room. Our instrumentation is constructed of an eco-friendly, biodegradable polymer.
Ossifix CEO, Mark Estrada, stated: “These initial sales are the foundation upon which we anticipate building exponential growth in sales We will begin rolling out the Jarvis bone pin immediately followed by additional products in the coming weeks.”
The Ossi?x Orthopedics™ line of products will compete in one of the fastest growing, emerging markets, speci?cally, the resorbable implant market, in three distinct surgical segments; orthopedic, dental, and general. Ossifix products are designed to be used in hospitals, ambulatory surgical centers, and specialty clinics. Distribution is scheduled throughout North America, and globally in Latin America, Europe, Asia Paci?c, as well as the Middle East and Africa. This global market is currently experiencing an estimated growth of 14% per year and is expected to reach $4.696 billion in sales this year.
Umbra Applied Technologies Group Chief Executive Officer, Alex Umbra, commented: "The level of thought and excellence that has gone into Ossifix products is something not commonly found in brands, but this is one that in my opinion will stand apart. We believe that its quality, precision, comprehensive layout and market segment provide it with significant competitive advantages. I believe that it will become apparent why we invested so heavily in this technology.”
U.S. based company, Ossifix Orthopedics™ products are manufactured in Austin, TX from select, high-density, allograft cortical bone. Ossifix’s unique manufacturing process and patent pending designs yield an engineered cortical bone implant that provides secure fixation and virtually eliminates any allergic or autoimmune reactions associated with metal or plastic/polymer implants. All Ossifix Orthopedics™ Pin, Screw and Plate Systems are single-use surgical kits containing all necessary instruments for implantation are based on decades of clinical experience in the operating room. Ossifix implants are shipped in comprehensive, sterile, single-use surgical kits designed in-house.
We expect Ossifix to post revenues within Q1 of 2022.
For more information about Ossifix Technologies go here: https://ossifixtech.com/
About Umbra Applied Technologies Group, Inc.
The firm is located in Tampa, Florida and focuses on advanced technologies across many disciplines. UAT Group is a holding company with interests in both public and private companies during the early stages of development as well as growth stages of companies with a synergistic business model to UAT Group subsidiaries.
For more information visit www.uatgroup.com
Investor and Media Contact: UAT Group at info@uatgroup.com
NEITHER THE SECURITIES EXCHANGE COMMISSION NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
Forward-Looking Information
This news release may include "forward-looking statements" including forecasts, estimates, expectations, and objectives for future operations including but not limited to its ability to conclude a business combination with a third party, sale of assets, return of capital or initial public offering and a secondary listing on the OTC as a result of aforementioned and its ability to fund the exploration of its assets through the raising of equity or debt capital or through funding by a joint venture partner that are
subject to a number of assumptions, risks, and uncertainties, many of which are beyond the control of Umbra Applied Technologies Group, including but not limited to capital markets and securities risks and continued development success on technology. There can be and are no actual or implied guarantees that any of the above activities will be completed or completed on terms acceptable to the Company and its shareholders or approved by any regulatory authority having jurisdiction. Such forward-looking information represents management's best judgment based on information currently available. No forward-looking statement can be guaranteed, and actual future results may vary materially. Umbra Applied Technologies Group does not assume the obligation to update any forward-looking statement, except as required by applicable law.
$UATG UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected
Press Release | 02/14/2022
Tampa, FL, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today that it has begun fulfilling purchase orders and contracts for orthopedic distributors and clients nationwide.
Ossifix engineers and manufactures 100% allograft bone implants for small bone, extremities, and sports medicine markets that also has applications in the craniofacial, spine and oral surgery procedures. Resorbable implant technology is readily accepted and used in today’s market, both domestically and globally. No regulatory approval is required for implantable fixation engineered from allograft bone. As a result, barriers to entry into the market for Ossifix Technologies implants are minimal.
Ossifix Orthopedics™ products are manufactured from select, high-density, allograft cortical bone. Ossifixs’ unique manufacturing process and patent pending designs yield an engineered cortical bone implant that provides secure fixation and virtually eliminates any allergic or autoimmune reactions associated with metal or plastic/polymer implants. All Ossifix Orthopedics™ Pin, Screw and Plate Systems are single-use surgical kits with all necessary instruments for implantation and are based on decades of clinical experience and use in the operating room. Our instrumentation is constructed of an eco-friendly, biodegradable polymer.
Ossifix CEO, Mark Estrada, stated: “These initial sales are the foundation upon which we anticipate building exponential growth in sales We will begin rolling out the Jarvis bone pin immediately followed by additional products in the coming weeks.”
The Ossi?x Orthopedics™ line of products will compete in one of the fastest growing, emerging markets, speci?cally, the resorbable implant market, in three distinct surgical segments; orthopedic, dental, and general. Ossifix products are designed to be used in hospitals, ambulatory surgical centers, and specialty clinics. Distribution is scheduled throughout North America, and globally in Latin America, Europe, Asia Paci?c, as well as the Middle East and Africa. This global market is currently experiencing an estimated growth of 14% per year and is expected to reach $4.696 billion in sales this year.
Umbra Applied Technologies Group Chief Executive Officer, Alex Umbra, commented: "The level of thought and excellence that has gone into Ossifix products is something not commonly found in brands, but this is one that in my opinion will stand apart. We believe that its quality, precision, comprehensive layout and market segment provide it with significant competitive advantages. I believe that it will become apparent why we invested so heavily in this technology.”
U.S. based company, Ossifix Orthopedics™ products are manufactured in Austin, TX from select, high-density, allograft cortical bone. Ossifix’s unique manufacturing process and patent pending designs yield an engineered cortical bone implant that provides secure fixation and virtually eliminates any allergic or autoimmune reactions associated with metal or plastic/polymer implants. All Ossifix Orthopedics™ Pin, Screw and Plate Systems are single-use surgical kits containing all necessary instruments for implantation are based on decades of clinical experience in the operating room. Ossifix implants are shipped in comprehensive, sterile, single-use surgical kits designed in-house.
We expect Ossifix to post revenues within Q1 of 2022.
For more information about Ossifix Technologies go here: https://ossifixtech.com/
About Umbra Applied Technologies Group, Inc.
The firm is located in Tampa, Florida and focuses on advanced technologies across many disciplines. UAT Group is a holding company with interests in both public and private companies during the early stages of development as well as growth stages of companies with a synergistic business model to UAT Group subsidiaries.
For more information visit www.uatgroup.com
Investor and Media Contact: UAT Group at info@uatgroup.com
NEITHER THE SECURITIES EXCHANGE COMMISSION NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
Forward-Looking Information
This news release may include "forward-looking statements" including forecasts, estimates, expectations, and objectives for future operations including but not limited to its ability to conclude a business combination with a third party, sale of assets, return of capital or initial public offering and a secondary listing on the OTC as a result of aforementioned and its ability to fund the exploration of its assets through the raising of equity or debt capital or through funding by a joint venture partner that are
subject to a number of assumptions, risks, and uncertainties, many of which are beyond the control of Umbra Applied Technologies Group, including but not limited to capital markets and securities risks and continued development success on technology. There can be and are no actual or implied guarantees that any of the above activities will be completed or completed on terms acceptable to the Company and its shareholders or approved by any regulatory authority having jurisdiction. Such forward-looking information represents management's best judgment based on information currently available. No forward-looking statement can be guaranteed, and actual future results may vary materially. Umbra Applied Technologies Group does not assume the obligation to update any forward-looking statement, except as required by applicable law.
$KLYG Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
Press Release | 02/14/2022
Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
PR Newswire
CANTON, Conn., Feb. 14, 2022
CANTON, Conn., Feb. 14, 2022 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2021.
"The company is excited to report that sales have increased for the fifth year in a row," said Ross Bjella, Kelyniam's CEO. "Despite Covid 2.0 shutdowns during the 1st quarter of 2021 and the Omicron variant shutdowns in the 4th quarter, Kelyniam achieved record operating profitability during 2021. This performance in the fourth year of our five-year plan confirms the company's ability to meet long and short term goals. Our objectives in 2022 are to accelerate profit and sales growth through our partnership with Fin-ceramica and the development and launch of organically-created complementary products."
Financial highlights for the year ended December 31, 2021the same period in 2020 includes:
Operating income of $180,445 compared to $49,683, an increase of 363.2%
Net Income $201,741 compared to $141,075, an increase of 43%
Total revenue of $ 2,664,434 compared to $2,512,101, an increase of 6.06%
The complete financials can be found on the company's website at www.Kelyniam.com.
Events that significantly affected the year and 4th quarter included:
The Company signed a new strategic distribution agreement with Fin-ceramica faenza Spa to market their CustomizedBone Hydroxyapatite Cranial Implant in the U.S.
Kelyniam received a patent on its Integrated Fixation System designs, marking a new level of intellectual property protection for its flagship product
Kelyniam is now issuing US GAAP-basis financials associated with a new SEC rule on the submission of current financial information through the broker portal of OTC Markets and is listed as a Pink Current Filer in OTCIQ
The company also hired Ms. Lisette Grunwell as the VP of Quality and Regulatory Affairs in January of this year.
"The addition of Lisette to our team is a testament to our commitment to quality and our ability to recruit high-talent professionals to our team. She brings a breadth and depth of knowledge about quality and regulatory matters to the company and will be an integral part of our executive team," said Bjella. "Kelyniam will continue to invest in infrastructure and partnerships necessary to achieve our objectives in 2022. While we cannot predict how Covid may affect the company in the future, we intend to have a solid platform to support continued growth."
Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxillo-facial implants for patients. Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site address is www.Kelyniam.com.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of ability to market products; and the risks described from time to time in the Company's SEC reports.
Cision View original content:https://www.prnewswire.com/news-releases/kelyniam-global-announces-record-sales-and-operating-profit-in-2021-financial-statements-301481317.html
$KLYG Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
Press Release | 02/14/2022
Kelyniam Global Announces Record Sales and Operating Profit in 2021 Financial Statements
PR Newswire
CANTON, Conn., Feb. 14, 2022
CANTON, Conn., Feb. 14, 2022 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2021.
"The company is excited to report that sales have increased for the fifth year in a row," said Ross Bjella, Kelyniam's CEO. "Despite Covid 2.0 shutdowns during the 1st quarter of 2021 and the Omicron variant shutdowns in the 4th quarter, Kelyniam achieved record operating profitability during 2021. This performance in the fourth year of our five-year plan confirms the company's ability to meet long and short term goals. Our objectives in 2022 are to accelerate profit and sales growth through our partnership with Fin-ceramica and the development and launch of organically-created complementary products."
Financial highlights for the year ended December 31, 2021the same period in 2020 includes:
Operating income of $180,445 compared to $49,683, an increase of 363.2%
Net Income $201,741 compared to $141,075, an increase of 43%
Total revenue of $ 2,664,434 compared to $2,512,101, an increase of 6.06%
The complete financials can be found on the company's website at www.Kelyniam.com.
Events that significantly affected the year and 4th quarter included:
The Company signed a new strategic distribution agreement with Fin-ceramica faenza Spa to market their CustomizedBone Hydroxyapatite Cranial Implant in the U.S.
Kelyniam received a patent on its Integrated Fixation System designs, marking a new level of intellectual property protection for its flagship product
Kelyniam is now issuing US GAAP-basis financials associated with a new SEC rule on the submission of current financial information through the broker portal of OTC Markets and is listed as a Pink Current Filer in OTCIQ
The company also hired Ms. Lisette Grunwell as the VP of Quality and Regulatory Affairs in January of this year.
"The addition of Lisette to our team is a testament to our commitment to quality and our ability to recruit high-talent professionals to our team. She brings a breadth and depth of knowledge about quality and regulatory matters to the company and will be an integral part of our executive team," said Bjella. "Kelyniam will continue to invest in infrastructure and partnerships necessary to achieve our objectives in 2022. While we cannot predict how Covid may affect the company in the future, we intend to have a solid platform to support continued growth."
Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxillo-facial implants for patients. Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site address is www.Kelyniam.com.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of ability to market products; and the risks described from time to time in the Company's SEC reports.
Cision View original content:https://www.prnewswire.com/news-releases/kelyniam-global-announces-record-sales-and-operating-profit-in-2021-financial-statements-301481317.html
$ABIT Athena Bitcoin Global Files Registration Statement on Form S-1
Press Release | 02/11/2022
Athena Bitcoin Global today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed resale of its Common Stock by existing shareholders. Athena Bitcoin Global stock is traded on the OTC Markets Pink Open Market under the ticker symbol "ABIT".
When available, the prospectus related to the registration statement may be obtained via the investor relations page on the Athena Bitcoin website (athenabitcoin.com), by contacting investor@athenabitcoin.com, or via the OTC Markets Website:
https://www.otcmarkets.com/stock/abit
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contacts
Press: press@athenabitcoin.com
Investor Relations: investor@athenabitcoin.com
This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the Securities Act), and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
$ABIT Athena Bitcoin Global Files Registration Statement on Form S-1
Press Release | 02/11/2022
Athena Bitcoin Global today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed resale of its Common Stock by existing shareholders. Athena Bitcoin Global stock is traded on the OTC Markets Pink Open Market under the ticker symbol "ABIT".
When available, the prospectus related to the registration statement may be obtained via the investor relations page on the Athena Bitcoin website (athenabitcoin.com), by contacting investor@athenabitcoin.com, or via the OTC Markets Website:
https://www.otcmarkets.com/stock/abit
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contacts
Press: press@athenabitcoin.com
Investor Relations: investor@athenabitcoin.com
This press release is being made pursuant to, and in accordance with, Rule 135 under the Securities Act of 1933, as amended (the Securities Act), and shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
$SOMC Southern Michigan Bancorp, Inc. Announces Fourth Quarter and Full Year 2021 Earnings
Press Release | 02/11/2022
COLDWATER, Mich., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) reported net income of $11,757,000 for 2021 compared to $7,386,000 for 2020. Diluted earnings per share were $2.58 for 2021 compared to $1.61 for 2020 after adjusting for the 100 percent stock dividend issued in May 2021. Fourth quarter 2021 net income was $2,522,000, or $0.56 per share, compared to $2,024,000, or $0.44 per share for the fourth quarter of 2020.
Total consolidated assets at December 31, 2021 increased 16.4 percent, reaching $1.16 billion compared to $997.6 million at December 31, 2020. Loan totals grew 16.6 percent, from December 31, 2020 levels of $635.9 million to $741.4 million. Deposits also increased to $974.4 million at December 31, 2021, an increase of $136.1 million or 16.2 percent, as compared to year end 2020.
Southern Michigan Bancorp, Inc., Chairman and Chief Executive Officer John H. Castle stated, “Net income was a record for the year, 36.4 percent higher than the previous high of $8,622,000 reported in 2019. Total assets, loans and deposits also continued to grow, expanding to new record highs at year end 2021. Excluding the forgiveness of $46.9 million of PPP loans during the year, loan growth exceeded $150 million. Additionally, the commercial loan pipeline remains strong. With liquidity remaining elevated, continued loan growth will be a key to positive earnings momentum in 2022.”
Southern provided $1.5 million for loan losses in 2021, with an allowance for loan losses at December 31, 2021 of $9,320,000, or 1.26% of loans. This compared to a provision for loan losses of $2.6 million for 2020, with an allowance for loan losses at December 31, 2020 of $7,789,000, or 1.22% of loans. Net loan loss recoveries totaled $31,000 for 2021 compared to $5,000 for 2020.
The return on average assets for 2021 was 1.06% compared to 0.82% for 2020. The return on average equity was 12.32% for 2021 compared to 8.36% for 2020. The tax equivalent net interest margins for 2021 and 2020 were 3.27% and 3.24%, respectively.
Southern Michigan Bancorp, Inc. is a bank holding company and the parent company of Southern Michigan Bank & Trust. It operates 13 branches within Branch, Calhoun, Hillsdale, Kalamazoo and St. Joseph Counties, providing a broad range of consumer, business and wealth management services throughout the region.
This press release contains forward-looking statements that are based on management’s beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy, and Southern Michigan Bancorp, Inc. Forward-looking statements are identifiable by words or phrases such as “expected,” “begin,” and other similar words or expressions. All statements with reference to a future time period are forward-looking. Management’s determination of the provision and allowance for loan losses and other accounting estimates, such as the carrying value of goodwill, other real estate owned and mortgage servicing rights and the fair value of investment securities (including whether any impairment on any investment security is temporary or other-than-temporary and the amount of any impairment), involves judgments that are inherently forward-looking. There can be no assurance that future loan losses will be limited to the amounts estimated. Our ability to successfully implement new programs and initiatives, increase efficiencies, maintain our current level of deposits and other sources of funding, respond to declines in collateral values and credit quality, and improve profitability is not entirely within our control and is not assured. The future effect of changes in the financial and credit markets and the national and regional economy on the banking industry, generally, and Southern Michigan Bancorp, Inc., specifically, are also inherently uncertain. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extend, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed in or implied by such forward-looking statements. Southern Michigan Bancorp, Inc. does not undertake to update forward-looking statements to reflect the impact of circumstances or events that may arise after the date of the forward-looking statements.
Southern Michigan Bancorp, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands, except share data)
December 31,
2021 December 31,
2020
ASSETS
Cash and cash equivalents $ 119,389 $ 99,610
Federal funds sold 271 231
Securities available for sale 245,846 208,380
Loans held for sale 1,146 1,691
Loans, net of allowance for loan losses of $9,320 - 2021 ($7,789 – 2020) 732,088 628,081
Premises and equipment, net 13,115 13,698
Accrued interest receivable 4,193 4,749
Net cash surrender value of life insurance 18,671 16,016
Goodwill 13,422 13,422
Other intangible assets, net 219 255
Other assets 12,794 11,441
TOTAL ASSETS $ 1,161,154 $ 997,574
LIABILITIES
Deposits :
Non-interest bearing $ 262,980 $ 220,786
Interest bearing 711,372 617,512
Total deposits 974,352 838,298
Securities sold under agreements to repurchase and overnight borrowings 20,609 20,083
Accrued expenses and other liabilities 13,930 14,561
Other borrowings 20,000 26,500
Subordinated debentures 34,514 5,155
Total liabilities 1,063,405 904,597
SHAREHOLDERS’ EQUITY
Preferred stock, 100,000 shares authorized; none issued or outstanding - -
Common stock, $2.50 par value:
Authorized - 10,000,000 shares
Issued and outstanding – 4,516,377 shares in 2021
(2,301,269 shares in 2020) 11,287 5,748
Additional paid-in capital 14,235 15,416
Retained earnings 71,581 67,741
Accumulated other comprehensive income, net 856 4,362
Unearned Employee Stock Ownership Plan shares (210 ) (290 )
Total shareholders’ equity 97,749 92,977
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,161,154 $ 997,574
Southern Michigan Bancorp, Inc.
condensed consolidated statements of income (unaudited)
(In thousands, except per share data)
Three Months Ended
December 31, Year Ended
December 31,
2021 2020 2021 2020
Interest income:
Loans, including fees $ 8,535 $ 7,202 $ 32,593 $ 28,377
Federal funds sold and balances with banks 41 33 148 314
Securities:
Taxable 843 643 3,330 2,482
Tax-exempt 269 185 1,069 645
Total interest income 9,688 8,063 37,140 31,818
Interest expense:
Deposits 485 800 2,268 4,025
Other 460 246 1,553 1,116
Total interest expense 945 1,046 3,821 5,141
Net interest income 8,743 7,017 33,319 26,677
Provision for loan losses 450 350 1,500 2,600
Net interest income after provision for loan losses 8,293 6,667 31,819 24,077
Non-interest income:
Service charges on deposit accounts 373 334 1,286 1,373
Trust fees 586 513 2,267 2,048
Net gains on loan sales 381 636 2,293 2,389
Earnings on life insurance assets 184 98 695 383
ATM and debit card fee income 463 394 1,823 1,543
Other 173 236 645 642
Total non-interest income 2,160 2,211 9,009 8,378
Non-interest expense:
Salaries and employee benefits 4,612 4,157 16,492 14,580
Occupancy, net 368 352 1,565 1,519
Equipment 313 300 1,174 1,180
Printing, postage and supplies 100 84 390 386
Telecommunication expenses 90 89 356 451
Professional and outside services 596 423 1,814 1,532
Software maintenance 449 400 1,677 1,552
ATM expenses 177 138 670 578
Other 771 497 2,570 1,888
Total non-interest expense 7,476 6,440 26,708 23,666
INCOME BEFORE INCOME TAXES 2,977 2,438 14,120 8,789
Federal income tax provision 455 414 2,363 1,403
NET INCOME $ 2,522 $ 2,024 $ 11,757 $ 7,386
Basic Earnings Per Common Share $ 0.56 $ 0.44 $ 2.59 $ 1,61
Diluted Earnings Per Common Share 0.56 0.44 2.58 1.61
Dividends Declared Per Common Share 0.12 0.12 0.48 0.46
CONTACT: John H. Castle, CEO
(517) 279-5500
$SOMC Southern Michigan Bancorp, Inc. Announces Fourth Quarter and Full Year 2021 Earnings
Press Release | 02/11/2022
COLDWATER, Mich., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) reported net income of $11,757,000 for 2021 compared to $7,386,000 for 2020. Diluted earnings per share were $2.58 for 2021 compared to $1.61 for 2020 after adjusting for the 100 percent stock dividend issued in May 2021. Fourth quarter 2021 net income was $2,522,000, or $0.56 per share, compared to $2,024,000, or $0.44 per share for the fourth quarter of 2020.
Total consolidated assets at December 31, 2021 increased 16.4 percent, reaching $1.16 billion compared to $997.6 million at December 31, 2020. Loan totals grew 16.6 percent, from December 31, 2020 levels of $635.9 million to $741.4 million. Deposits also increased to $974.4 million at December 31, 2021, an increase of $136.1 million or 16.2 percent, as compared to year end 2020.
Southern Michigan Bancorp, Inc., Chairman and Chief Executive Officer John H. Castle stated, “Net income was a record for the year, 36.4 percent higher than the previous high of $8,622,000 reported in 2019. Total assets, loans and deposits also continued to grow, expanding to new record highs at year end 2021. Excluding the forgiveness of $46.9 million of PPP loans during the year, loan growth exceeded $150 million. Additionally, the commercial loan pipeline remains strong. With liquidity remaining elevated, continued loan growth will be a key to positive earnings momentum in 2022.”
Southern provided $1.5 million for loan losses in 2021, with an allowance for loan losses at December 31, 2021 of $9,320,000, or 1.26% of loans. This compared to a provision for loan losses of $2.6 million for 2020, with an allowance for loan losses at December 31, 2020 of $7,789,000, or 1.22% of loans. Net loan loss recoveries totaled $31,000 for 2021 compared to $5,000 for 2020.
The return on average assets for 2021 was 1.06% compared to 0.82% for 2020. The return on average equity was 12.32% for 2021 compared to 8.36% for 2020. The tax equivalent net interest margins for 2021 and 2020 were 3.27% and 3.24%, respectively.
Southern Michigan Bancorp, Inc. is a bank holding company and the parent company of Southern Michigan Bank & Trust. It operates 13 branches within Branch, Calhoun, Hillsdale, Kalamazoo and St. Joseph Counties, providing a broad range of consumer, business and wealth management services throughout the region.
This press release contains forward-looking statements that are based on management’s beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy, and Southern Michigan Bancorp, Inc. Forward-looking statements are identifiable by words or phrases such as “expected,” “begin,” and other similar words or expressions. All statements with reference to a future time period are forward-looking. Management’s determination of the provision and allowance for loan losses and other accounting estimates, such as the carrying value of goodwill, other real estate owned and mortgage servicing rights and the fair value of investment securities (including whether any impairment on any investment security is temporary or other-than-temporary and the amount of any impairment), involves judgments that are inherently forward-looking. There can be no assurance that future loan losses will be limited to the amounts estimated. Our ability to successfully implement new programs and initiatives, increase efficiencies, maintain our current level of deposits and other sources of funding, respond to declines in collateral values and credit quality, and improve profitability is not entirely within our control and is not assured. The future effect of changes in the financial and credit markets and the national and regional economy on the banking industry, generally, and Southern Michigan Bancorp, Inc., specifically, are also inherently uncertain. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extend, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed in or implied by such forward-looking statements. Southern Michigan Bancorp, Inc. does not undertake to update forward-looking statements to reflect the impact of circumstances or events that may arise after the date of the forward-looking statements.
Southern Michigan Bancorp, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands, except share data)
December 31,
2021 December 31,
2020
ASSETS
Cash and cash equivalents $ 119,389 $ 99,610
Federal funds sold 271 231
Securities available for sale 245,846 208,380
Loans held for sale 1,146 1,691
Loans, net of allowance for loan losses of $9,320 - 2021 ($7,789 – 2020) 732,088 628,081
Premises and equipment, net 13,115 13,698
Accrued interest receivable 4,193 4,749
Net cash surrender value of life insurance 18,671 16,016
Goodwill 13,422 13,422
Other intangible assets, net 219 255
Other assets 12,794 11,441
TOTAL ASSETS $ 1,161,154 $ 997,574
LIABILITIES
Deposits :
Non-interest bearing $ 262,980 $ 220,786
Interest bearing 711,372 617,512
Total deposits 974,352 838,298
Securities sold under agreements to repurchase and overnight borrowings 20,609 20,083
Accrued expenses and other liabilities 13,930 14,561
Other borrowings 20,000 26,500
Subordinated debentures 34,514 5,155
Total liabilities 1,063,405 904,597
SHAREHOLDERS’ EQUITY
Preferred stock, 100,000 shares authorized; none issued or outstanding - -
Common stock, $2.50 par value:
Authorized - 10,000,000 shares
Issued and outstanding – 4,516,377 shares in 2021
(2,301,269 shares in 2020) 11,287 5,748
Additional paid-in capital 14,235 15,416
Retained earnings 71,581 67,741
Accumulated other comprehensive income, net 856 4,362
Unearned Employee Stock Ownership Plan shares (210 ) (290 )
Total shareholders’ equity 97,749 92,977
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,161,154 $ 997,574
Southern Michigan Bancorp, Inc.
condensed consolidated statements of income (unaudited)
(In thousands, except per share data)
Three Months Ended
December 31, Year Ended
December 31,
2021 2020 2021 2020
Interest income:
Loans, including fees $ 8,535 $ 7,202 $ 32,593 $ 28,377
Federal funds sold and balances with banks 41 33 148 314
Securities:
Taxable 843 643 3,330 2,482
Tax-exempt 269 185 1,069 645
Total interest income 9,688 8,063 37,140 31,818
Interest expense:
Deposits 485 800 2,268 4,025
Other 460 246 1,553 1,116
Total interest expense 945 1,046 3,821 5,141
Net interest income 8,743 7,017 33,319 26,677
Provision for loan losses 450 350 1,500 2,600
Net interest income after provision for loan losses 8,293 6,667 31,819 24,077
Non-interest income:
Service charges on deposit accounts 373 334 1,286 1,373
Trust fees 586 513 2,267 2,048
Net gains on loan sales 381 636 2,293 2,389
Earnings on life insurance assets 184 98 695 383
ATM and debit card fee income 463 394 1,823 1,543
Other 173 236 645 642
Total non-interest income 2,160 2,211 9,009 8,378
Non-interest expense:
Salaries and employee benefits 4,612 4,157 16,492 14,580
Occupancy, net 368 352 1,565 1,519
Equipment 313 300 1,174 1,180
Printing, postage and supplies 100 84 390 386
Telecommunication expenses 90 89 356 451
Professional and outside services 596 423 1,814 1,532
Software maintenance 449 400 1,677 1,552
ATM expenses 177 138 670 578
Other 771 497 2,570 1,888
Total non-interest expense 7,476 6,440 26,708 23,666
INCOME BEFORE INCOME TAXES 2,977 2,438 14,120 8,789
Federal income tax provision 455 414 2,363 1,403
NET INCOME $ 2,522 $ 2,024 $ 11,757 $ 7,386
Basic Earnings Per Common Share $ 0.56 $ 0.44 $ 2.59 $ 1,61
Diluted Earnings Per Common Share 0.56 0.44 2.58 1.61
Dividends Declared Per Common Share 0.12 0.12 0.48 0.46
CONTACT: John H. Castle, CEO
(517) 279-5500
$SFLM SFLMaven CEO Joe Ladin Discusses Metaverse Strategy on MoneyTV
Press Release | 02/11/2022
FORT LAUDERDALE, FL, Feb. 11, 2022 (GLOBE NEWSWIRE) -- SFLMaven Corp. (OTC Pink: SFLM), ("SFLMaven" or the "Company") (www.sflmaven.com), a leading provider of high-end luxury goods, is pleased to announce that Joseph Ladin, the Company’s CEO, returned to MoneyTV for another in-depth interview with Donald Baillargeon.
The interview went live this morning and can be accessed Here.
In the interview, Ladin discussed the Company’s formation of a new division focused on the Metaverse. Ladin noted that the Company plans to engage in the design and sale of digital antique jewelry, collectibles, and art for the Metaverse, as well as the establishment of a gallery and store within the Metaverse.
The Company will fund this process through cash flows from current operations related to its core jewelry business, which has pulled in over $140 million in sales over the past two decades.
SFLMaven is also actively shopping for Metaverse real estate and plans to establish a position very soon. The Company is currently leaning toward establishing this position in Decentraland.
As discussed in the interview, the demand for “skins” and virtual accessories has proven to be a durable and rapidly growing opportunity, as evidenced by Fortnite’s $5.7 billion in sales of virtual accessories in 2020. The Company believes the market for classic luxury goods in digital form in the Metaverse holds enormous promise as well.
Ladin also noted that the Company’s NFT strategy – as outlined last fall – dovetails perfectly with its Metaverse ambitions.
Follow SFLMaven on social media:
Twitter: @sflmaven
Instagram: sflmaven
About SFLMaven
SFLMaven Corp. (OTC Pink: SFLM) is a premium provider of high-end luxury goods to a global base of discerning patrons. Famous for its Thursday Night Auction events on its top-rated eBay store, SFLMaven has driven over $140 million in sales since inception, earning more than 100k positive reviews along the way.
For more information, please visit the Company's website at www.sflmaven.com.
FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements, including information about management's view of SFLMaven Corp.'s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words 'believes,' 'expects,' 'intends,' 'plans,' 'anticipates,' or 'may,' and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of SFLMaven, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on SFLMaven's future results. The forward-looking statements included in this press release are made only as of the date hereof. SFLMaven cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, SFLMaven undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by SFLMaven.
SOURCE: SFLMaven Corp.
Corporate Contact
info@sflmaven.com
Public Relations
EDM Media, LLC
https://edm.media
$SFLM SFLMaven CEO Joe Ladin Discusses Metaverse Strategy on MoneyTV
Press Release | 02/11/2022
FORT LAUDERDALE, FL, Feb. 11, 2022 (GLOBE NEWSWIRE) -- SFLMaven Corp. (OTC Pink: SFLM), ("SFLMaven" or the "Company") (www.sflmaven.com), a leading provider of high-end luxury goods, is pleased to announce that Joseph Ladin, the Company’s CEO, returned to MoneyTV for another in-depth interview with Donald Baillargeon.
The interview went live this morning and can be accessed Here.
In the interview, Ladin discussed the Company’s formation of a new division focused on the Metaverse. Ladin noted that the Company plans to engage in the design and sale of digital antique jewelry, collectibles, and art for the Metaverse, as well as the establishment of a gallery and store within the Metaverse.
The Company will fund this process through cash flows from current operations related to its core jewelry business, which has pulled in over $140 million in sales over the past two decades.
SFLMaven is also actively shopping for Metaverse real estate and plans to establish a position very soon. The Company is currently leaning toward establishing this position in Decentraland.
As discussed in the interview, the demand for “skins” and virtual accessories has proven to be a durable and rapidly growing opportunity, as evidenced by Fortnite’s $5.7 billion in sales of virtual accessories in 2020. The Company believes the market for classic luxury goods in digital form in the Metaverse holds enormous promise as well.
Ladin also noted that the Company’s NFT strategy – as outlined last fall – dovetails perfectly with its Metaverse ambitions.
Follow SFLMaven on social media:
Twitter: @sflmaven
Instagram: sflmaven
About SFLMaven
SFLMaven Corp. (OTC Pink: SFLM) is a premium provider of high-end luxury goods to a global base of discerning patrons. Famous for its Thursday Night Auction events on its top-rated eBay store, SFLMaven has driven over $140 million in sales since inception, earning more than 100k positive reviews along the way.
For more information, please visit the Company's website at www.sflmaven.com.
FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements, including information about management's view of SFLMaven Corp.'s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words 'believes,' 'expects,' 'intends,' 'plans,' 'anticipates,' or 'may,' and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of SFLMaven, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on SFLMaven's future results. The forward-looking statements included in this press release are made only as of the date hereof. SFLMaven cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, SFLMaven undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by SFLMaven.
SOURCE: SFLMaven Corp.
Corporate Contact
info@sflmaven.com
Public Relations
EDM Media, LLC
https://edm.media
$GTVH Golden Triangle Ventures Inc. Provides Update on Financial Disclosures and Previously Announced Dividend
Press Release | 02/11/2022
LAS VEGAS, Feb. 11, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTVH” or the “Company”) announces an update in regard to its financial disclosures and limited information status. The Company is pleased to share that it has completed 11 draft financial disclosure statements and is near completion of its previously announced restatement of every financial statement published under GTVH since the Company completed its merger with Texas Oil & Minerals, Inc. (“TOMI”).
The Company previously disclosed that it had detected some discrepancies in its 2Q 2021 financial statements, all of which have been reviewed and corrected by F.A.R. Out Numbered, LLC (“FAR”) accounting services. The management team has been working closely with FAR to address the many pertinent items needed in order for the Company to move forward and complete its anticipated audit after the completed restatement.
The Company is honored to work with Felicia A. Rossi with F.A.R. Out Numbered, who was appointed as the new corporate accountant/controller, enrolled agent and licensed tax consultant of Golden Triangle Ventures, Inc. Rossi has been working closely with management to assist the Company in preparing its financials for its anticipated audit, for the specific purpose of uplisting and becoming a fully reporting SEC filer, which is needed to complete the two anticipated spinoffs.
Since the appointment of FAR, every entity bank account has been reconciled from inception to date, every transaction within all entities has been reviewed and categorized, and the electronic filing system has been revamped and populated with all bank statements for all entities. The Company master shareholder list was dissected, reconciled and verified, which followed the creation of reproducible formulas for continuing the master issuance list indefinitely and consistently. The electronic filing system was populated with all contracts and documentation associated with the master issuance list, and all stock issuance totals were calculated and confirmed with consistent formatting by type of issuance and segregated per quarter and year.
In addition, FAR created, dissected, verified and confirmed the Company’s convertible note amortization schedule; created and populated a quarterly contracted service expenses log based on issuances for service contracts; booked all quarterly expenses for its service contracts since inception; and reconciled and verified every contribution made, by every contributor, within each entity, for every month and year. FAR also created a system for consistent treatment of accounting data groups, such as, but not limited to, bank data entry, SPAs, service contracts, issuances, electronic filing and more. This resulted in a consolidation of all information, by entity, by quarter, into one financial picture to become “audit ready” at a transactional level.
The Company is now completing a final review of all data, material events, shareholder issuances and all other information within its financial statement drafts to ensure the accuracy and timeline of events within its corporate history before filing its disclosures. As the Company completes its final review, all statements will be formatted and then submitted to OTC Markets so the Company’s legal counsel can complete the annual attorney letter needed to obtain a current status.
Steffan Dalsgaard, CEO of Golden Triangle Ventures, states, “Words cannot express how grateful we are to have the help and assistance of Felicia and all she has provided us over the past few months. The amount of work that we have done to get to where we are today is beyond anything I could ever fully explain. I am extremely confident in our ability to become audited, and I am very excited to get through this goal and begin sharing so many exciting developments within all companies under our umbrella.”
About Golden Triangle Ventures, Inc.
Golden Triangle Ventures, Inc. (GTV) is a multifaceted consulting company pursuing ventures in the health, entertainment, technology, fulfillment and food & beverage industries, with many additional projects being developed that provide synergistic values to these divisions. The Company aims to purchase, acquire and/or joint venture with established entities that management can assist and help develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion for and commitment to these marketplaces. The Company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services.
www.GoldenTriangleInc.com
HEALTH DIVISION
Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the medical PPE space as well as the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services, which include a full retail line of high-end, all-natural health, wellness and beauty products created by Le Pragma, which the company is currently working to acquire in full. To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop shop for all of the company's products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.
www.GTVHealth.com
ENTERTAINMENT DIVISION
Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting electronic dance music concerts in Las Vegas. Lavish Entertainment is currently doing business as (DBA) "EpicRaves," which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is building an immersive virtual reality platform to help monetize its livestreamed concerts and assist its business in expanding into markets outside of Las Vegas. The company has also launched its own record label, called Syndicate Bass Records, to showcase some of the best bass music artists in the world and provide a platform to highlight their music. Lavish Entertainment has a partnership with Sahara Event Center, which is a 68,000-square-foot event center where the company organizes some of its larger concerts. Management has a vision of acquiring a large-scale venue to develop the most advanced event center in the world.
www.LavishEntertainment.com
www.EpicRaves.com
TECHNOLOGY DIVISION
HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called "HyGrO," which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures, Inc. is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies, Inc. has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream. This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Multiple third-party commercial farms and testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive. Company headquarters have moved into a 7,800-square-foot, state-of-the-art manufacturing facility located in Florida while executing a three-year lease with an option to purchase the entire 24,000-square-foot building.
www.HyFrontier.com
FOOD & BEVERAGE
Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures and a synergistic business with a mission of providing a world-class portfolio of unique brands that are all birthed from Napa Valley and Sonoma Valley in the heart of California’s wine country. The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere. Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready to become cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.
www.NapaWineBrands.com
SONDER FULFILLMENT
Sonder Fulfillment is a wholly owned subsidiary of Golden Triangle Ventures, providing an array of synergies to the many companies and projects within GTV. Sonder Fulfillment is a leading company in the industrial hemp and CBD industry. Sonder Fulfillment has put together a powerful team of research Ph.Ds, formulary scientists and flavor compounding specialists to build advanced cannabinoid-based nutritional and homeopathic products that are designed to catalyze the endocannabinoid system (ECS) to support targeted wellness and relief. The company’s management team has built many well-known products in the natural medicine space for several decades and has coalesced that knowledge to build out superior processes and products. Sonder Fulfillment has strong and longstanding relationships with farms, extraction labs, product formulation labs and co-packaging companies, which allows Sonder Fulfillment to secure the complete supply chain from start to finish and provide its clients with the lowest cost of goods sold as possible while maintaining the highest-quality standards in the industry. Sonder Fulfillment has produced for and currently has white-label contracts for some of the largest CBD companies in the space, such as Select (a division of CURA), Amway and many others. The company provides bulk raw CBD materials to clients in 22 countries and is now paving the way to become the first company to provide legally commercialized end-consumer CBD products into “hard-to-penetrate” markets such as Japan, Australia, South Korea and Mexico. Sonder Fulfillment has partnered with GVB Biopharma, one of the largest industrial hemp processors in the space, to undertake the extensive and rigorous process of getting active pharmaceutical ingredient (API) certification for raw products. API certification will allow Sonder Fulfillment to further expand its reach into markets where CBD can only be distributed through prescriptions as a medicinal product.
www.SonderFulfillment.com
FORWARD-LOOKING INFORMATION
Certain information set forth in this press release contains "forward-looking information," including "future-oriented financial information" and "financial outlook," under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect to the future so they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance, and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material nonpublic information. In this regard, investors and others should note that we announce material financial information on our company website, www.GoldenTriangleInc.com, in addition to SEC filings, press releases, public conference calls and webcasts. We also use social media to communicate with the public about our company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, in light of the SEC's guidance, we encourage investors, the media and others interested in our company to review the information we post on the following U.S. social media channels:
Twitter: www.twitter.com/GTV_Inc
Telegram: https://t.me/GTVINC
CONTACT INFORMATION
Golden Triangle Ventures, Inc.
3035 E Patrick Ln. #15
Las Vegas, NV 89120
info@GoldenTriangleInc.com
1-800-469-2614
Corporate Communications
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
$GTVH Golden Triangle Ventures Inc. Provides Update on Financial Disclosures and Previously Announced Dividend
Press Release | 02/11/2022
LAS VEGAS, Feb. 11, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTVH” or the “Company”) announces an update in regard to its financial disclosures and limited information status. The Company is pleased to share that it has completed 11 draft financial disclosure statements and is near completion of its previously announced restatement of every financial statement published under GTVH since the Company completed its merger with Texas Oil & Minerals, Inc. (“TOMI”).
The Company previously disclosed that it had detected some discrepancies in its 2Q 2021 financial statements, all of which have been reviewed and corrected by F.A.R. Out Numbered, LLC (“FAR”) accounting services. The management team has been working closely with FAR to address the many pertinent items needed in order for the Company to move forward and complete its anticipated audit after the completed restatement.
The Company is honored to work with Felicia A. Rossi with F.A.R. Out Numbered, who was appointed as the new corporate accountant/controller, enrolled agent and licensed tax consultant of Golden Triangle Ventures, Inc. Rossi has been working closely with management to assist the Company in preparing its financials for its anticipated audit, for the specific purpose of uplisting and becoming a fully reporting SEC filer, which is needed to complete the two anticipated spinoffs.
Since the appointment of FAR, every entity bank account has been reconciled from inception to date, every transaction within all entities has been reviewed and categorized, and the electronic filing system has been revamped and populated with all bank statements for all entities. The Company master shareholder list was dissected, reconciled and verified, which followed the creation of reproducible formulas for continuing the master issuance list indefinitely and consistently. The electronic filing system was populated with all contracts and documentation associated with the master issuance list, and all stock issuance totals were calculated and confirmed with consistent formatting by type of issuance and segregated per quarter and year.
In addition, FAR created, dissected, verified and confirmed the Company’s convertible note amortization schedule; created and populated a quarterly contracted service expenses log based on issuances for service contracts; booked all quarterly expenses for its service contracts since inception; and reconciled and verified every contribution made, by every contributor, within each entity, for every month and year. FAR also created a system for consistent treatment of accounting data groups, such as, but not limited to, bank data entry, SPAs, service contracts, issuances, electronic filing and more. This resulted in a consolidation of all information, by entity, by quarter, into one financial picture to become “audit ready” at a transactional level.
The Company is now completing a final review of all data, material events, shareholder issuances and all other information within its financial statement drafts to ensure the accuracy and timeline of events within its corporate history before filing its disclosures. As the Company completes its final review, all statements will be formatted and then submitted to OTC Markets so the Company’s legal counsel can complete the annual attorney letter needed to obtain a current status.
Steffan Dalsgaard, CEO of Golden Triangle Ventures, states, “Words cannot express how grateful we are to have the help and assistance of Felicia and all she has provided us over the past few months. The amount of work that we have done to get to where we are today is beyond anything I could ever fully explain. I am extremely confident in our ability to become audited, and I am very excited to get through this goal and begin sharing so many exciting developments within all companies under our umbrella.”
About Golden Triangle Ventures, Inc.
Golden Triangle Ventures, Inc. (GTV) is a multifaceted consulting company pursuing ventures in the health, entertainment, technology, fulfillment and food & beverage industries, with many additional projects being developed that provide synergistic values to these divisions. The Company aims to purchase, acquire and/or joint venture with established entities that management can assist and help develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion for and commitment to these marketplaces. The Company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services.
www.GoldenTriangleInc.com
HEALTH DIVISION
Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the medical PPE space as well as the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services, which include a full retail line of high-end, all-natural health, wellness and beauty products created by Le Pragma, which the company is currently working to acquire in full. To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop shop for all of the company's products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.
www.GTVHealth.com
ENTERTAINMENT DIVISION
Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting electronic dance music concerts in Las Vegas. Lavish Entertainment is currently doing business as (DBA) "EpicRaves," which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is building an immersive virtual reality platform to help monetize its livestreamed concerts and assist its business in expanding into markets outside of Las Vegas. The company has also launched its own record label, called Syndicate Bass Records, to showcase some of the best bass music artists in the world and provide a platform to highlight their music. Lavish Entertainment has a partnership with Sahara Event Center, which is a 68,000-square-foot event center where the company organizes some of its larger concerts. Management has a vision of acquiring a large-scale venue to develop the most advanced event center in the world.
www.LavishEntertainment.com
www.EpicRaves.com
TECHNOLOGY DIVISION
HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called "HyGrO," which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures, Inc. is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies, Inc. has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream. This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Multiple third-party commercial farms and testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive. Company headquarters have moved into a 7,800-square-foot, state-of-the-art manufacturing facility located in Florida while executing a three-year lease with an option to purchase the entire 24,000-square-foot building.
www.HyFrontier.com
FOOD & BEVERAGE
Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures and a synergistic business with a mission of providing a world-class portfolio of unique brands that are all birthed from Napa Valley and Sonoma Valley in the heart of California’s wine country. The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere. Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready to become cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.
www.NapaWineBrands.com
SONDER FULFILLMENT
Sonder Fulfillment is a wholly owned subsidiary of Golden Triangle Ventures, providing an array of synergies to the many companies and projects within GTV. Sonder Fulfillment is a leading company in the industrial hemp and CBD industry. Sonder Fulfillment has put together a powerful team of research Ph.Ds, formulary scientists and flavor compounding specialists to build advanced cannabinoid-based nutritional and homeopathic products that are designed to catalyze the endocannabinoid system (ECS) to support targeted wellness and relief. The company’s management team has built many well-known products in the natural medicine space for several decades and has coalesced that knowledge to build out superior processes and products. Sonder Fulfillment has strong and longstanding relationships with farms, extraction labs, product formulation labs and co-packaging companies, which allows Sonder Fulfillment to secure the complete supply chain from start to finish and provide its clients with the lowest cost of goods sold as possible while maintaining the highest-quality standards in the industry. Sonder Fulfillment has produced for and currently has white-label contracts for some of the largest CBD companies in the space, such as Select (a division of CURA), Amway and many others. The company provides bulk raw CBD materials to clients in 22 countries and is now paving the way to become the first company to provide legally commercialized end-consumer CBD products into “hard-to-penetrate” markets such as Japan, Australia, South Korea and Mexico. Sonder Fulfillment has partnered with GVB Biopharma, one of the largest industrial hemp processors in the space, to undertake the extensive and rigorous process of getting active pharmaceutical ingredient (API) certification for raw products. API certification will allow Sonder Fulfillment to further expand its reach into markets where CBD can only be distributed through prescriptions as a medicinal product.
www.SonderFulfillment.com
FORWARD-LOOKING INFORMATION
Certain information set forth in this press release contains "forward-looking information," including "future-oriented financial information" and "financial outlook," under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company's business, projects and joint ventures; (iv) execution of the Company's vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company's projects; (vi) completion of the Company's projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company's current customer, supplier and other material agreements; and (vii) future liquidity, working capital and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management's beliefs and opinions in respect to the future so they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not guarantees of future performance, and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements. The Securities and Exchange Commission ("SEC") has provided guidance to issuers regarding the use of social media to disclose material nonpublic information. In this regard, investors and others should note that we announce material financial information on our company website, www.GoldenTriangleInc.com, in addition to SEC filings, press releases, public conference calls and webcasts. We also use social media to communicate with the public about our company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, in light of the SEC's guidance, we encourage investors, the media and others interested in our company to review the information we post on the following U.S. social media channels:
Twitter: www.twitter.com/GTV_Inc
Telegram: https://t.me/GTVINC
CONTACT INFORMATION
Golden Triangle Ventures, Inc.
3035 E Patrick Ln. #15
Las Vegas, NV 89120
info@GoldenTriangleInc.com
1-800-469-2614
Corporate Communications
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
$PRRY Planet Resource Recovery Inc. Appoints Galen Reich as President of PRRY
Press Release | 02/11/2022
SARASOTA, FL / ACCESSWIRE / February 11, 2022 / Planet Resource Recovery, Inc. (OTC PINK:PRRY) is pleased to officially appoint Galen Reich as its new President.
Mr. Reich served as General Manager and Marketing Manager of Recreatives Industries Inc., the original manufacturer of MAX Amphibious All-Terrain Vehicles, from 1993 until 2013. During his time at Recreatives, he expanded the business by maintaining over 150 vendor relationships and managing inventory control at foundries, heat-treating firms, machining firms, and assembly plants.
Mr. Reich further expanded the company's dealership network nationwide nearly 50% per-annum compounded growth over a five year period, resulting in over 750 new MAX ATV dealers. Mr. Reich's implementation of direct-response marketing through print media, online and search-engine keyword advertising achieved 6.2% average annual increase in unit revenue over a nine-year span.
"Galen's comprehensive experience in manufacturing and marketing MAX ATVs gives us strong confidence in PRRY's success with relaunching the brand," states Andrew Lapp, CEO. "Upon Galen's effective date of March 1st, we will immediately begin re-establishing our vendor supply chain to get vehicles and accessories into production. We also plan to collaborate with 1-2 former MAX engineers from the Recreatives era to assist with necessary tasks including the inspection and testing of pre-production samples of vehicle parts and accessories. The MAX brand has proven to be a huge success in North America, which gives us assurance in expanding into international markets around the world."
Stay tuned for more frequent updates from PRRY as the company continues moving forward in revitalizing MAX Amphibious All-Terrain Vehicles.
About Planet Resource Recovery Inc.
Currently headquartered in Sarasota, Florida, Planet Resource Recovery, Inc. is the manufacturer of MAX Six-Wheel Drive Amphibious All-Terrain Vehicles. First launched in 1969, MAX ATVs have been used in numerous applications relating to recreation, hunting, commercial, industrial, and military. Planet Resource Recovery Inc. will produce the MAX ATV product line along with MAX parts and MAX factory original accessories. For more information about PRRY, visit our new corporate website at www.recreatives.com or contact Investor Relations at ir@recreatives.com / (561) 402-8025.
$RHCO READEN HOLDING CORPORATION (OTC PINK: RHCO) ANNOUNCES FILING OF DECEMBER 31, 2021 FINANCIAL STATEMENTS WITH OTC MARKETS, REVENUE UP 67.7%
Press Release | 02/11/2022
READEN HOLDING CORPORATION (OTC PINK: RHCO) ANNOUNCES FILING OF DECEMBER 31, 2021 FINANCIAL STATEMENTS WITH OTC MARKETS, REVENUE UP 67.7%
READEN HOLDING CORPORATION (OTC PINK: RHCO), a Venture Capital Corporation which is active in the Fintech, Online Payment and E-commerce industries, today announced that the Company has filed its financial statements for the quarter ending December 2021 with OTC Markets Disclosure & News Service. RHCO reported an increase in Revenue of 67.70% compared to the quarter ending September 2021. The Company recorded a minor loss yet compared to last quarter the loss was cut down by 88.63%. Net Assets saw an increase of 1.45%.
The positive result was due to the soft launch of OkeApp (www.okepartners.com), the Companys new discount referral app. A notable number of new merchants were signed up before the holiday season and started to generate revenue. The Company also see Revenue increased in Readies (www.readies.biz), its own developed e-voucher. The uptrend of OkeApp and Readies is expected to continue in 2022, as both businesses will be flourish in full speed. OkeApp has welcomed more merchants and members before Chinese New Year, and Readies online platform will be evolving into an online distributor which start to offer more than 200 popular prepaid gift cards for sale.
In an earlier announcement, the Company announced that its Fintech Division, which includes OkePay, OkeApp and Readies, has recorded a 700% revenue gain in January 2022 comparing to December 2021. That one months revenue approximately equals to the total revenue of the Division in the last six months of 2021.
Richard Klitsie, CEO of RHCO stated, RHCO is happy to announce the completion of its quarterly filing. The result is indeed promising, and the management strongly believes that this is only the beginning of something great coming. We have anticipated last quarter to be the last one with a losing result, and we are more than confident that this first quarter of 2022 will see a notable profit. We are looking forward to a fruitful year ahead, and I think all RHCOs shareholders should be as excited as we are.
Readen Holding Corp. (www.readenholdingcorp.com) is a publicly traded Venture Capital Corporation, with major holdings in the Fintech Industry and has been increasing its investment in E-commerce and E-payment sectors, such as;
www.okepay.biz
www.readies.biz
www.okepartners.com
www.oktoken.biz
www.neckermanndirect.eu
www.twopercent.hk
www.fligrofood.com
RHCO is a diversified holding company, with an operating history of over 30 years, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns, in order to maximize value for all shareholders. RHCO has subsidiaries and liaison offices in Europe and Asia.
For further information please contact RHCO at info@readenholdingcorp.com
or +852 3950 5911
The RHCO corporate email address is info@readenholdingcorp.com
The RHCO corporate website can be accessed at www.readenholdingcorp.com
The RHCO Twitter account can be accessed at https://twitter.com/readenrhco
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Readen Holding Corp. to accomplish its stated plan of business. Readen Holding Corp. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Readen Holding Corp. or any other person.
Contact
Readen Holding Corp.
info@readenholdingcorp.com
+852 3950 5911
$RHCO READEN HOLDING CORPORATION (OTC PINK: RHCO) ANNOUNCES FILING OF DECEMBER 31, 2021 FINANCIAL STATEMENTS WITH OTC MARKETS, REVENUE UP 67.7%
Press Release | 02/11/2022
READEN HOLDING CORPORATION (OTC PINK: RHCO) ANNOUNCES FILING OF DECEMBER 31, 2021 FINANCIAL STATEMENTS WITH OTC MARKETS, REVENUE UP 67.7%
READEN HOLDING CORPORATION (OTC PINK: RHCO), a Venture Capital Corporation which is active in the Fintech, Online Payment and E-commerce industries, today announced that the Company has filed its financial statements for the quarter ending December 2021 with OTC Markets Disclosure & News Service. RHCO reported an increase in Revenue of 67.70% compared to the quarter ending September 2021. The Company recorded a minor loss yet compared to last quarter the loss was cut down by 88.63%. Net Assets saw an increase of 1.45%.
The positive result was due to the soft launch of OkeApp (www.okepartners.com), the Companys new discount referral app. A notable number of new merchants were signed up before the holiday season and started to generate revenue. The Company also see Revenue increased in Readies (www.readies.biz), its own developed e-voucher. The uptrend of OkeApp and Readies is expected to continue in 2022, as both businesses will be flourish in full speed. OkeApp has welcomed more merchants and members before Chinese New Year, and Readies online platform will be evolving into an online distributor which start to offer more than 200 popular prepaid gift cards for sale.
In an earlier announcement, the Company announced that its Fintech Division, which includes OkePay, OkeApp and Readies, has recorded a 700% revenue gain in January 2022 comparing to December 2021. That one months revenue approximately equals to the total revenue of the Division in the last six months of 2021.
Richard Klitsie, CEO of RHCO stated, RHCO is happy to announce the completion of its quarterly filing. The result is indeed promising, and the management strongly believes that this is only the beginning of something great coming. We have anticipated last quarter to be the last one with a losing result, and we are more than confident that this first quarter of 2022 will see a notable profit. We are looking forward to a fruitful year ahead, and I think all RHCOs shareholders should be as excited as we are.
Readen Holding Corp. (www.readenholdingcorp.com) is a publicly traded Venture Capital Corporation, with major holdings in the Fintech Industry and has been increasing its investment in E-commerce and E-payment sectors, such as;
www.okepay.biz
www.readies.biz
www.okepartners.com
www.oktoken.biz
www.neckermanndirect.eu
www.twopercent.hk
www.fligrofood.com
RHCO is a diversified holding company, with an operating history of over 30 years, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns, in order to maximize value for all shareholders. RHCO has subsidiaries and liaison offices in Europe and Asia.
For further information please contact RHCO at info@readenholdingcorp.com
or +852 3950 5911
The RHCO corporate email address is info@readenholdingcorp.com
The RHCO corporate website can be accessed at www.readenholdingcorp.com
The RHCO Twitter account can be accessed at https://twitter.com/readenrhco
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Readen Holding Corp. to accomplish its stated plan of business. Readen Holding Corp. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Readen Holding Corp. or any other person.
Contact
Readen Holding Corp.
info@readenholdingcorp.com
+852 3950 5911
$CLABF Core One Labs Completes Strategic Acquisition of Awakened Biosciences and its Game-Changing Provisional Patents
Press Release | 02/11/2022
VANCOUVER, British Columbia., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”), a life sciences biotechnology company focused on research, development, and production of API grade psychedelic compounds, as well as the advancement of psychedelic assisted treatments for various mental health and neurological disorders, is pleased to announce that it has completed the acquisition (the “Transaction”) of all of the outstanding share capital of Awakened Biosciences Inc. (“Awakened”).
Awakened is a psychedelics research and technology company that has successfully developed novel technologies for the production of synthetic psilocybin, the synthetic production of psilocybin and psilocin analogues, and for the manufacturing of various no-psychoactive psilocybin-based prodrugs. All of Awakened’s production methods have the potential to produce resultant compounds at scale, and at significantly reduced costs when compared to other production methods of the same name.
Awakened’s novel production methods have resulted in the filing of three (3) provisional patents applications with the United States Patent and Trademark Office (USPTO) for protection of these proprietary technologies.
The Transaction presents many significant and immediate benefits to the Company, including expanding the Company’s portfolio of subsidiaries specializing in the research and development of psychedelic compounds, as well as an expansion in the spectrum of methods Core One’s scientists can employ in producing psychedelic-based formulations.
Successful employment of Awakened’s patent-pending production technologies could also result in revenue generation for the Company, as some of the patent-pending methods, and resultant analogues produced, could be sold, and shipped without Controlled Drug and Substances Act (CDSA) restrictions.
The Transaction also increases the Company’s catalogue of psychedelic compounds available for clinical and medicinal research, including an array of prodrugs that would be produced from the new technologies.
Normally designed to improve bioavailability, a prodrug is described as a medication or a compound that is metabolized into a pharmacologically active drug after administration. For psychedelic compounds, prodrugs would contain the same medicinal benefits associated with psychedelics while eliminating the hallucinogenic effects.
Awakened is led by Dr. Tony Durst, an Emeritus Professor at the University of Ottawa, and renowned specialist in medicinal and natural product chemistry. Dr. Durst is a co-inventor of 14 patents applications, 14 awarded. He is a founder of Souroubea Botanicals Inc., and a 2013 Queen Elizabeth 60th Silver Jubilee medal recipient.
The addition of Dr. Durst, along with his established relationship with the University of Ottawa, further compliments Core One’s strong scientific team led by Dr. Robert Hancock, CEO of the Company’s subsidiary Vocan Biotechnology, and establishes a relationship with another one of Canada’s leading scientific research universities, as the Company continues to build an impressive roster of leading scientific researchers.
“This acquisition is yet another illustration of Core One’s commitment to become a leading biotechnology and life sciences enterprise in the psychedelic sector. With the addition of Awakened to the Core One family, the Company has increased expansion opportunities, furthered its psychedelic products portfolio, and secured potential for immediate revenue generation. All of these factors lead toward greater market share for the Company, and to increased shareholder value,” stated Joel Shacker, Core One CEO.
Transaction Details
The Transaction was completed pursuant to a share purchase agreement among the Company, Awakened and the shareholders of Awakened (the “Definitive Agreement”) dated effective February 9, 2022. Pursuant to the Definitive Agreement, and in consideration for the acquisition of Awakened, the Company has issued 7,030,000 common shares and 1,458,200 share purchase warrants entitling the holders to acquire an equivalent number of common shares of the Company at a price of $1.15 per share until February 4, 2024.
The Company is at arms-length from Awakened and its shareholders. The Transaction neither constitutes a fundamental change nor a change of business for the Company, nor has it resulted in a change of control of the Company within the meaning applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Transaction, the Company has issued 140,600 common shares to certain third-parties who provided administrative services necessary to complete the Transaction.
About Core One Labs Inc.
Core One is a biotechnology research and technology life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. Core One has developed a patent pending thin film oral strip (the “technology”) which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. The Company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. Core One also holds an interest in medical clinics which maintain a combined database of over 275,000 patients. Through these clinics, the integration of its intellectual property, R&D related to psychedelic treatments and novel drug therapies, the Company intends to obtain regulatory research approval for the advancement of psychedelic-derived treatments for mental health disorders.
Core One Labs Inc.
Joel Shacker
Chief Executive Officer
FOR MORE INFORMATION, PLEASE CONTACT:
info@core1labs.com
1-866-347-5058
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions, and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with strict regulatory regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
In addition, psilocybin is currently a Schedule III drug under the Controlled Drugs and Substances Act (Canada) and it is a criminal offence to possess substances under the Controlled Drugs and Substances Act (Canada) without a prescription or authorization. Health Canada has not approved psilocybin as a drug for any indication. Core One does not have any direct or indirect involvement with illegal selling, production, or distribution of psychedelic substances in jurisdictions in which it operates. While Core One believes psychedelic substances can be used to treat certain medical conditions, it does not advocate for the legalization of psychedelics substances for recreational use. Core One does not deal with psychedelic substances, except within laboratory and clinical trial settings conducted within approved regulatory frameworks.
$CLABF Core One Labs Completes Strategic Acquisition of Awakened Biosciences and its Game-Changing Provisional Patents
Press Release | 02/11/2022
VANCOUVER, British Columbia., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”), a life sciences biotechnology company focused on research, development, and production of API grade psychedelic compounds, as well as the advancement of psychedelic assisted treatments for various mental health and neurological disorders, is pleased to announce that it has completed the acquisition (the “Transaction”) of all of the outstanding share capital of Awakened Biosciences Inc. (“Awakened”).
Awakened is a psychedelics research and technology company that has successfully developed novel technologies for the production of synthetic psilocybin, the synthetic production of psilocybin and psilocin analogues, and for the manufacturing of various no-psychoactive psilocybin-based prodrugs. All of Awakened’s production methods have the potential to produce resultant compounds at scale, and at significantly reduced costs when compared to other production methods of the same name.
Awakened’s novel production methods have resulted in the filing of three (3) provisional patents applications with the United States Patent and Trademark Office (USPTO) for protection of these proprietary technologies.
The Transaction presents many significant and immediate benefits to the Company, including expanding the Company’s portfolio of subsidiaries specializing in the research and development of psychedelic compounds, as well as an expansion in the spectrum of methods Core One’s scientists can employ in producing psychedelic-based formulations.
Successful employment of Awakened’s patent-pending production technologies could also result in revenue generation for the Company, as some of the patent-pending methods, and resultant analogues produced, could be sold, and shipped without Controlled Drug and Substances Act (CDSA) restrictions.
The Transaction also increases the Company’s catalogue of psychedelic compounds available for clinical and medicinal research, including an array of prodrugs that would be produced from the new technologies.
Normally designed to improve bioavailability, a prodrug is described as a medication or a compound that is metabolized into a pharmacologically active drug after administration. For psychedelic compounds, prodrugs would contain the same medicinal benefits associated with psychedelics while eliminating the hallucinogenic effects.
Awakened is led by Dr. Tony Durst, an Emeritus Professor at the University of Ottawa, and renowned specialist in medicinal and natural product chemistry. Dr. Durst is a co-inventor of 14 patents applications, 14 awarded. He is a founder of Souroubea Botanicals Inc., and a 2013 Queen Elizabeth 60th Silver Jubilee medal recipient.
The addition of Dr. Durst, along with his established relationship with the University of Ottawa, further compliments Core One’s strong scientific team led by Dr. Robert Hancock, CEO of the Company’s subsidiary Vocan Biotechnology, and establishes a relationship with another one of Canada’s leading scientific research universities, as the Company continues to build an impressive roster of leading scientific researchers.
“This acquisition is yet another illustration of Core One’s commitment to become a leading biotechnology and life sciences enterprise in the psychedelic sector. With the addition of Awakened to the Core One family, the Company has increased expansion opportunities, furthered its psychedelic products portfolio, and secured potential for immediate revenue generation. All of these factors lead toward greater market share for the Company, and to increased shareholder value,” stated Joel Shacker, Core One CEO.
Transaction Details
The Transaction was completed pursuant to a share purchase agreement among the Company, Awakened and the shareholders of Awakened (the “Definitive Agreement”) dated effective February 9, 2022. Pursuant to the Definitive Agreement, and in consideration for the acquisition of Awakened, the Company has issued 7,030,000 common shares and 1,458,200 share purchase warrants entitling the holders to acquire an equivalent number of common shares of the Company at a price of $1.15 per share until February 4, 2024.
The Company is at arms-length from Awakened and its shareholders. The Transaction neither constitutes a fundamental change nor a change of business for the Company, nor has it resulted in a change of control of the Company within the meaning applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Transaction, the Company has issued 140,600 common shares to certain third-parties who provided administrative services necessary to complete the Transaction.
About Core One Labs Inc.
Core One is a biotechnology research and technology life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. Core One has developed a patent pending thin film oral strip (the “technology”) which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. The Company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. Core One also holds an interest in medical clinics which maintain a combined database of over 275,000 patients. Through these clinics, the integration of its intellectual property, R&D related to psychedelic treatments and novel drug therapies, the Company intends to obtain regulatory research approval for the advancement of psychedelic-derived treatments for mental health disorders.
Core One Labs Inc.
Joel Shacker
Chief Executive Officer
FOR MORE INFORMATION, PLEASE CONTACT:
info@core1labs.com
1-866-347-5058
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions, and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with strict regulatory regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.
In addition, psilocybin is currently a Schedule III drug under the Controlled Drugs and Substances Act (Canada) and it is a criminal offence to possess substances under the Controlled Drugs and Substances Act (Canada) without a prescription or authorization. Health Canada has not approved psilocybin as a drug for any indication. Core One does not have any direct or indirect involvement with illegal selling, production, or distribution of psychedelic substances in jurisdictions in which it operates. While Core One believes psychedelic substances can be used to treat certain medical conditions, it does not advocate for the legalization of psychedelics substances for recreational use. Core One does not deal with psychedelic substances, except within laboratory and clinical trial settings conducted within approved regulatory frameworks.
$MNNDF NUROSENE & CYCLICA PARTNER TO DEVELOP NOVEL DRUGS FOR NEURODEGENERATIVE DISEASES
Press Release | 02/10/2022
NUROSENE & CYCLICA PARTNER TO DEVELOP NOVEL DRUGS FOR NEURODEGENERATIVE DISEASES
PR Newswire
TORONTO, Feb. 10, 2022
Nurosene's NetraAI Engine at the forefront to accelerate Drug Discovery with Leading Pharma Research Company
TORONTO, Feb. 10, 2022 /PRNewswire/ - Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on delivering innovative AI based technology solutions for mental performance and wellness, is partnering, via its wholly owned subsidiary NetraMark Corp. ("NetraMark"), with Cyclica Inc. ("Cyclica"), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline. This partnership agreement, signed February 7th, 2022, will leverage NetraHealthAtlas, one of Nurosene's core proprietary AI tools, to accelerate drug discovery targeting neurodegenerative diseases, a market valued at almost USD $40 Billion1. Furthermore, this partnership agreement incorporates a commercializing party milestone payment schedule and royalty payments to be payable pursuant to the terms of license agreements to be entered into between the parties as compounds are developed.
Nurosene Health Inc. (CNW Group/Nurosene Health Inc.)
Nurosene, via NetraMark, will lead in the discovery phase of the research process by identifying specific drug targets. This partnership will demonstrate the power of NetraHealthAtlas to accelerate drug target identification and to significantly reduce the costs and time associated with bringing a drug to market. Nurosene's NetraHealthAtlas is the next generation of machine intelligence designed to generate insights about patient populations and different aspects of disease. NetraHealthAtlas creates highly accurate hypotheses about invisible causal factors from patient sub-populations and then recommends ways to target a disease by exploring the necessary biochemistry involved. NetraHealthAtlas applies the learnings to treatment at a more individual level by stratifying patient data into accurate sub-models which allows for the discovery of unknown insights, unattainable with other methods and traditional AI.
"Observing the Netra Health Atlas create accurate hypotheses in less than an hour, about diseases that have taken years for pharmaceutical companies to discover, is very exciting. We have now reached a point where our AI is teaching us how to approach curing disease. The drugs that can be developed from this partnership have the potential to change the way we treat neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, profoundly impacting millions of patients and their families around the world," says Chief Scientific Officer of Nurosene, Dr. Joseph Geraci, PhD.
Naheed Kurji, Cyclica's President, CEO and Co-Founder, outlines his enthusiasm for the partnership, stating: "We're thrilled to be continuing to build our biotech pipeline of the future on the global stage alongside Nurosene. The NetraHealthAtlas has the ability to triangulate diseases by offering sets of targets that can work together. This unique feature fits beautifully with our poly-pharmacological approach at Cyclica, where we can attack disease from multiple approaches simultaneously."
Cyclica will use its AI-augmented drug discovery platform to discover novel drug candidates in an efficient manner for drug targets discovered by NetraHealthAtlas. The process for this partnership involves using Nurosene's technology to generate lists of protein targets from patient level genetic data of various types and will allow Cyclica's polypharmacology-enabled platform to predict molecular candidates for selected protein targets that can then be tested for disease altering properties.
"Working with a leading drug discovery company to tackle neurodegenerative diseases is an exciting opportunity for us. Through this partnership with Cyclica, we are leveraging our advanced approach to AI to develop an ecosystem that will drive the development of new molecules years faster while helping to significantly reduce clinical trial failure rates and costs by hundreds of millions of dollars," says NetraMark's President, Mark Smithyes.
About NetraMark
NetraMark, an AI and pharma-tech company, has developed proprietary next generation AI solutions for pharmaceutical and biotechnology companies. These solutions allow us to leverage small to large data sets in order to prevent clinical trial failure, identify biomarkers, implement adaptive trials, accelerate drug discovery, and enable drug repurposing and resurrection. NetraMark is a wholly owned subsidiary of Nurosene Health Inc.
For more information, visit www.netramark.com
About Nurosene
Nurosene provides individuals with tools and technology that empower them to take control of their mental wellness. Our mission is to build the next generation of better, healthier brains by leveraging technological advancements in AI. With our team of experts and partners, Nurosene is positioned at the leading edge of critical research and innovations, striving to disrupt traditional mental wellness treatments.
For more information, visit www.nurosene.com.
About Cyclica
Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of disease. Our work spans dozens of collaborations with large pharma and biotech as well as several joint ventures. We are a passionate team of biotech and pharma professionals, biologists, chemists, and computer scientists who live and labour at the intersection of our collective expertise. To learn more about Cyclica and how we partner, please visit www.cyclicarx.com.
For further information about Cyclica, please contact:
Jennifer Sacco, Director of Marketing and Communications
jennifer.sacco@cyclicarx.com
Forward-Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which is based upon Nurosene's current internal expectations, estimates, projections, assumptions and beliefs, and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Specifically, this news release contains forward looking statements relating to, among others, Nurosene's research activities through its wholly owned subsidiary, NetraMark Corp. in partnership with Cyclica Inc., its potential results, uses and the impact of the research including the identification of drug candidates and acceleration of a drug IP portfolio, the importance of the research, possible enhancements to our technology and clinical trial AI offering, growth, and other initiatives related thereto.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Nurosene does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise. New factors emerge from time to time, and it is not possible for Nurosene to predict all such factors. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in Nurosene's Final Long Form Prospectus dated May 20, 2021 and Management's Discussion and Analysis for the year ended September 30, 2021 ("MD&A"), and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in Nurosene's Final Long Form Prospectus and MD&A could cause actual events or results to differ materially from those described in any forward-looking information.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
1 https://www.mordorintelligence.com/industry-reports/neurodegenerative-disease-market#:~:text=The%20Neurodegenerative%20Disease%20market%20was,2.30%25%20over%20the%20forecast%20period.
Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nurosene--cyclica-partner-to-develop-novel-drugs-for-neurodegenerative-diseases-301480163.html